Skip to main content
Erschienen in: BMC Cancer 1/2023

Open Access 01.12.2023 | Research

Unmet supportive care needs of breast cancer survivors: a systematic scoping review

verfasst von: Rongrong Fan, Lili Wang, Xiaofan Bu, Wenxiu Wang, Jing Zhu

Erschienen in: BMC Cancer | Ausgabe 1/2023

Abstract

Background

Breast cancer is the most common type of cancer in women worldwide. Though improved treatments and prolonged overall survival, breast cancer survivors (BCSs) persistently suffer from various unmet supportive care needs (USCNs) throughout the disease. This scoping review aims to synthesize current literature regarding USCNs among BCSs.

Methods

This study followed a scoping review framework. Articles were retrieved from Cochrane Library, PubMed, Embase, Web of Science, and Medline from inception through June 2023, as well as reference lists of relevant literature. Peer-reviewed journal articles were included if USCNs among BCSs were reported. Inclusion/exclusion criteria were adopted to screen articles’ titles and abstracts as well as to entirely assess any potentially pertinent records by two independent researchers. Methodological quality was independently appraised following Joanna Briggs Institute (JBI) critical appraisal tools. Content analytic approach and meta-analysis were performed for qualitative and quantitative studies respectively. Results were reported according to the PRISMA extension for scoping reviews.

Results

A total of 10,574 records were retrieved and 77 studies were included finally. The overall risk of bias was low to moderate. The self-made questionnaire was the most used instrument, followed by The Short-form Supportive Care Needs Survey questionnaire (SCNS-SF34). A total of 16 domains of USCNs were finally identified. Social support (74%), daily activity (54%), sexual/intimacy (52%), fear of cancer recurrence/ spreading (50%), and information support (45%) were the top unmet supportive care needs. Information needs and psychological/emotional needs appeared most frequently. The USCNs was found to be significantly associated with demographic factors, disease factors, and psychological factors.

Conclusion

BCSs are experiencing a large number of USCNs in fearing of cancer recurrence, daily activity, sexual/intimacy, psychology and information, with proportions ranging from 45% to 74%. Substantial heterogeneity in study populations and assessment tools was observed. There is a need for further research to identify a standard evaluation tool targeted to USCNs on BCSs. Effective interventions based on guidelines should be formulated and conducted to decrease USCNs among BCSs in the future.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Breast cancer is a global cause for concern owing to its high incidence among women around the world [1]. According to the Global Cancer Statistics 2020 [2], female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases (11.7%). With improvements in early detection, surgery, and adjuvant therapy for breast cancer, long-term survival and cure are becoming possible. It is estimated that currently, 5-year survival rates are in the range of 90%, and 10-year survival is about 80% [3]. Quality of life is thus becoming a major issue for these patients. Nevertheless, many of them continue to be burdened by psychological distress and poor quality of life throughout their cancer trajectory [4]. Postoperative complications and side effects of chemoradiotherapy leave serious impacts on multiple aspects of their life, resulting in fatigue, sleep disorder, limb dysfunction [5], and even severe psychological matters [6]. Some recent studies unveiled that BCSs has endorsed moderate to high levels of depressive symptoms, anxiety, and post-traumatic stress [7]. Therefore, they report increased supportive care needs that require high-quality care in the domains of psychosocial, informational, and relational perspective [8, 9].
Supportive care encompasses a person-centered approach to care that aims to help a person with cancer and their family to meet their needs at multiple levels, from pre-diagnosis through the process of diagnosis and treatment to cure, continuing illness or death and into bereavement [10, 11]. The term “supportive care needs” is an umbrella term covering the physical, informational, emotional, practical, social, and spiritual needs of a person affected by cancer [12].
To ensure patients’ needs are addressed, there has been an increasing interest in supportive care needs assessment. Needs that were not well addressed and where additional support was required were classified as ‘unmet needs’ [11]. There is a growing body of literature that recognizes the significance of unmet supportive care needs (USCNs) among BCSs [1315]. In the healthcare field, USCN reflects incongruity between the supports that an individual perceives to be necessary versus the actual supports provided [16]. It can be seen as covering a spectrum of healthcare needs that are not optimally met [17]. USCNs assessment is a patient‐oriented approach, which can lead resources to be distributed efficiently, and bring better outcomes for patients as finite medical resources could be directed to the benefit of patients with the greatest needs [18]. The ultimate goal is increasingly aligned and predictable pathway for the management and assessment, to meet the most required supportive care needs.
There is increasing evidence that USCNs can have a detrimental effect on BCSs’ well-being [19]. Accurate identification of USCNs of BCSs not only increases their satisfaction, but also improve their quality of life [20, 21]. Nevertheless, the knowledge about the most primary USCNs breast cancer patients are facing remains inadequate and unclear. Systematic reviews regarding USCNs were performed in some cancer groups, such as advanced cancer patients and their caregivers [22], prostate cancer patients [23], lung cancer [24], bladder cancer [25], and head and neck cancer [26]. Despite much observational study has been conducted, limited research has focused on any systematic review into USCNs among BCSs. A comprehensive understanding of USCNs among BCSs is crucial to direct future research and clinical practice. Therefore, a cohesive and up-to-date synthesis of the literature is needed to describe the USCNs of BCSs, which can inform the design and delivery of quality supportive care for this growing and diverse subpopulation, as well as guiding thinking to shape effective, evidence-based interventions. The main objective of this systematic scoping review is to identify, analyze and synthesize existing literature regarding the USCNs among BCSs and organize them into a structure from which the reader can obtain an in-depth understanding of this topic.

Methods

Review framework

This study employed a scoping review methodology to examine the range and scope of the available literature on the investigated topic, producing a rigorous synthesis and disseminating the existing evidence to date. The scoping review followed a methodological framework including the following five-stage process [27]: identifying the research question; identifying relevant studies; study selection; charting the data; and collating, summarizing, and reporting the results.
This review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines Extension for Scoping Reviews (PRISMA-ScR) [28]. The protocol was registered in PROSPERO with a registration number of CRD42022360528.

Review questions

1.
What are the USCNs of BCSs?
 
2.
How many categories of domains of USCNs can be divided?
 
3.
Which USCNs accounts the most proportion among BCSs?
 
4.
What are the factors that might influence the USCNs?
 

Search strategy

An extensive search strategy was conducted in Cochrane Library, PubMed, Embase, Web of Science, and Medline from inception through June 2023. Medical subject headings (MeSH) and text words were used to identify studies. The search strategy for ‘unmet supportive care need’ was Search #1: “needs assessment” [MeSH Terms] OR “needs assessment” [Title/Abstract] OR “assessment of healthcare needs” [Title/Abstract] OR “assessment of health care needs” [Title/ Abstract] OR “unmet needs” [Title/Abstract] OR “supportive care” [Title/Abstract] OR “need” [Title/Abstract]. The search strategy for ‘breast cancer survivor’ was Search #2: "breast neoplasms"[MeSH Terms] OR “breast neoplasms” [Title/Abstract] OR “breast cancer” [Title/Abstract] OR “breast tumor” [Title/Abstract] OR “breast oncology” [Title/Abstract]. An extended range search was carried out through ‘Search #1’ And ‘Search #2’. Furthermore, a snowballing strategy was also used with reference lists of relevant literature to locate additional studies not identified in the search strategies.

Eligibility criteria

Participants criteria

According to the definition of the National Cancer Institute (NCI), survivor signifies one who remains alive and continues to function during and after overcoming a serious hardship or life-threatening disease. In cancer, a person is considered to be a survivor from the time of diagnosis until the end of life. It can be extended that breast cancer survivors refer to breast cancer individuals from the time of breast cancer diagnosis through the process of their lifespan. Thus, breast cancer survivors and breast cancer patients were both regarded as survivors in the present study. The criteria for participants were determined based on this premise: adult survivors (≥ 18 years) who were diagnosed with breast cancer, regardless of cancer stage, and current treatment, were eligible.

Studies

Studies investigating USCNs of BCSs were included. The eligibility criteria for selecting studies are listed as follows:

Inclusion criteria

  • • Any study published in a peer-reviewed journal of qualitative or quantitative design.
  • • English articles were included only to obtain articles with enough authoritativeness and professionalism, as well as to avoid language barriers and translation bias.
  • • USCNs were reported as primary or secondary outcomes (or expressed in terms of an unresolved desire for support/service provision/concerns that are explicitly referred to and measured as ‘unmet needs’).

Exclusion Criteria

  • • Conference articles, abstracts, editorial comments, guidelines, or unpublished works.
  • • Any study that included a mixed population, the results were reported together and could not be separated for breast cancer.
  • • The reported outcome from patients in the terminal or end-of-life care phase (final weeks/days of life).
  • • Any study solely focused on the presence of quality of life, satisfaction, or some specific unmet need (such as unmet symptoms/ psychology problems/ reproductive concerns/ rehabilitation/ diet and so on).

Quality assessment

For each included study, methodological quality was independently appraised by two authors following Joanna Briggs Institute (JBI) critical appraisal checklist, which was recommended for studies reporting prevalence data and also suitable for qualitative studies [29]. It aims to assess the methodological quality of studies and to determine the extent to which a study has addressed the possibility of bias in its design, conduct, and analysis. When disagreement occurred, a consensus was reached by discussion. The JBI critical appraisal checklist for qualitative research and prevalence research could be divided into 10 and 9 measurement properties, respectively. As for mixed studies, we used both tools for each part. For the qualitative part, JBI critical appraisal checklist for qualitative research was used. For the quantitative part, JBI critical appraisal checklist for studies reporting prevalence data was applied. Each question option can be rated as “yes”, “no”, “unclear”, or “not applicable”. In each item, the percentage of each option was calculated and multiplied by 100%. The higher ‘yes’ responses on the appraisal items indicated a study of superior quality. The risk of bias scores was categorized based on “yes” rates as ≥ 80% (low), 60 to 80% (moderate), and < 60% (high).

Study selection and data extraction

Two independent researchers performed double-checks on literature screening and data extracting. In an initial round of screening, study authors reviewed the titles and abstracts in the consolidated dataset for relevance based on the abovementioned inclusion/exclusion criteria. In a secondary screening, articles were reviewed in their entirety and incorporated into the present review if they met the eligibility criteria. Disagreements were addressed via frequent discussions with a third independent author or between the authors. A final set of articles fitting the scope of the present review were analyzed and summarized. A pre-defined Excel form was formulated specifically for this review to facilitate the extraction of pertinent data. The columns of the characteristics of the included studies were designed and the key information relevant to the review question were recorded. Essential information was extracted from eligible articles involving title, authors, country of origin, year of publication, sample size, population demographics, research design, assessment tools, main finding, the proportion of unmet needs, and factors related to USCNs. Whereby studies measured USCNs at multiple time points, all data corresponding to the different time points were extracted. However, only baseline measures were used for data synthesis in tables and figures.

Data analysis and synthesis

For qualitative studies, the content analytic approach was applied to narrative synthesis. For quantitative studies that reported the prevalence of USCNs, total participants, domain categories and proportion were recorded and calculated. If there was any study that reported two or more USCNs with varying proportions in a given domain, the median proportion was calculated (i.e., if a study reported multiple items in the domain of unmet psychological need, such as stress, anxiety, and depression with different proportions, the median proportion was calculated to represent the whole rate of the domain). The larger median proportion indicates a higher USCN.
The meta-analysis was performed using Review Manager Software (version 5.3). The pooled proportions (with respective 95% CIs) for each domain were calculated. To explore heterogeneity between the studies the I2 statistics were used. Given the heterogeneity of estimates, a random-effects model was set. When I2 was > 0.50% the statistical heterogeneity was considered substantial. We limited meta-analysis to quantitative studies that applied comprehensive (multiple domains) needs assessments: This was to ensure some comparability between pooled studies, and to avoid inflation of estimates that may arise from targeted assessment in a single domain. Tables and bar charts will be used to present the main results.

Results

A total of 10,574 records were retrieved. After excluding 2803 duplicates, a total of 7771 studies were retrieved for titles and abstracts screening. After screening for titles and abstracts, 7471 articles were excluded and 300 papers were retrieved for full-text review. The final 77 articles were included, which consisted of 21 qualitative studies, 52 quantitative studies, and 4 mixed studies. The flow chart of the literature search is shown in Fig. 1.

Quality assessment

The overall risk of bias is shown in Figs. 2 and 3. More than 6o% of the quantitative studies had ‘Yes’ responses to all nine items. Nearly 34.5% had ‘No’ responses to the “Condition was measured in a standard, reliable way for all participants” item and “Valid methods were used for the identification of the condition” item. A few studies had “Unclear” responses on the “Study subjects and the setting were described in detail” item (about 25.6%). Among qualitative studies, nearly 60% of articles had “No” responses to the “Is there a statement locating the researcher culturally or theoretically?” item. Nearly 29% of articles had “Unclear” responses to the “Is the influence of the researcher on the research, and vice-versa, addressed?” item, and 67% had “No” responses to the “Is there a statement locating the researcher culturally or theoretically?” item.

Literature characteristics

The final 77 articles were included, which consisted of 52 quantitative studies, 21 qualitative studies, and 4 mixed studies [3032]. For mixed studies, the quantitative part was assigned as the quantitative study, and qualitative part was assigned as the qualitative study. Therefore, there are 56 quantitative studies and 25 qualitative studies that were included in the final analysis. The literature characteristics were summarized in Table 1. The publication period is from 2004 to 2023. There were 33 (42.9%) studies that are published after 2018. The United States, China, Korea, Australia, and the UK published the most articles. Most quantitative studies were cross-sectional design. The most used instrument was the self-made questionnaire (19, 33.9%) [3350], followed by The Short-form Supportive Care Needs Survey questionnaire (SCNS-SF34) (12, 23.2%) [31, 5163], Supportive Care Needs Survey (5, 8.9%) (SCNS) [6468], Cancer Survivors Unmet Needs (3, 5.4%) (CaSUN) [19, 69, 70] and The Comprehensive Needs Assessment Tool (2, 3.6%) (CNAT) [30, 71]. In-depth, semi-structured interview was the most used approach in qualitative studies. The majority of the participants included in this review were women diagnosed with breast cancer who were in the post-treatment period. Only five studies involved objects who were undergoing treatment. There were 16 domains of USCN were finally identified, they were: physical/symptom need, psychological/emotional need, fear of cancer recurrence/ spreading, family support, medical support, social support, financial support, sexual/intimacy need, coping/survival need, daily activity need, spiritual support, information support, medical counseling, peer communication, cognitive needs, and dignity.
Table 1
Literature characteristics
Author team
Year
Country
Study Design
Supportive Care Needs Assessment Tool
Number
Participant
Age
Domains
Baker et al. [33]
2019
UK
Cross-sectional
SMQ
980
BCSs during or after cancer treatment
50–54
PS: 67.2%, PE: 77.6%
Vuksanovic et al. [72]
2021
Australia
Cross-sectional
CSUNQ
130
BCSs diagnosed at least one year
NR
PS: 29.1%, PE: 31.6%, FCR: 41.1%, Inf: 26.1%, MC: 29.9%
Abdollahzadeh et al. [64]
2014
Iran
Cross-sectional
SCNS
136
BCSs who finished the initial treatment
46.8 ± 10.1
PS: 67.8%, PE: 62.7%, FS: 60.5%, Sex: 59.1%, Act: 67.8%, Inf: 70.7%
Akechi et al. [51]
2011
Japan
Cross-sectional
SCNS-SF34
408
BCSs at all stages and at any time point after diagnosis
56.1 ± 12.1
PE: 48%, FCR: 63%, Inf: 45.5%, MC: 50%
Autade et al. [34]
2021
India
Cross-sectional
SMQ
120
BCSs at any stage and have completed primary treatment
52
PS: 100%, PE: 100%, FS: 40%, Cop: 32.5%, SP: 40%
Barr et al. [15]
2020
Victoria
Cross-sectional
SCNS-Breast
202
Young BCSs in early survivorship diagnosed with stage I or stage II
43.5 ± 5.0
PE: 67.5%, Act: 63%, Inf: 64%, MC: 64%, PC: 44%
Batehup et al. [19]
2021
UK
Cross-sectional
CaSUN
540
BCSs in the first 8 months post-primary treatment
61.2 ± 11.6
FS: 85.2%, MS: 85%, SS: 90.9%, Sex: 86.3%, SP: 92%, Inf: 89.2%, Cog: 82.1%, PC: 87%
Bu et al. [73]
2022
Chinese
Mainland
Cross-sectional
CSP-BC
1210
BCSs who had completed primary therapy
NR
FCR:69%, MS:49.7%, SS: 52%, Fns:48.5%, Act:53.1%, Inf:54.3%, MC:63.2%, Dig:59.5%
Burris et al. [69]
2015
USA
Cross-sectional
CaSUN
90
BCSs at stage I-III and had plans for radiation therapy
55.26
PS: 25.3%, PE: 27.6%, FCR: 31%, Fns: 28.7%, Cop: 31%, Inf: 36.7%, MC: 36.8%
Capelan et al. [74]
2017
UK
Cross-sectional
HNA + EPR
625
BCSs at the early stage(I–III) who had completed initial treatment
59 ± 13
PS: 55%, PE: 24%, FS: 5%, Cop: 6%, SP: 4%
Cheng et al. [52]
2014
Singapore
Cross-sectional
SCNS-SF34
150
BCSs at six months to five years post-treatment period
55.1 ± 8
PS: 44%, PE: 29%, Inf: 37%
Choi et al. [65]
2013
Chinese
Mainland
Cross-sectional
SCNS
163
BCSs who completed first-line cancer treatment
NR
Inf: 59%
Chou et al. [75]
2022
Taiwan
China
Cross-sectional
Records
1129
BCSs who were receiving treatment
46–55
PS: 3.5%, PE: 40.4%, MC: 11.9%, MS: 24.6%, Fns: 0.2%
Chua et al. [76]
2020
Singapore
Cross-sectional
MCCC-CSSN
438
BCSs
56 (25–81)
PS: 46.2%, FCR: 55%, MS: 37.4%
Chyon et al. [53]
2016
Korea
Cross-sectional
SCNS-SF34
117
BCSs before adjuvant therapy
45.1 ± 7.25
PS: 51.7%, PE: 57.7%, FCR: 79.5%, MC: 51.7%, Cop: 49.6%, Act: 52.7%, Inf: 65%
de Ligt et al. [35]
2019
Netherlands
Cross-sectional
SMQ
404
BCSs at early-stage during treatment
62 ± 10.9
PS: 63.4%, PE: 53%
Dugan et al. [36]
2021
USA
Cross-sectional
SMQ
76
BCSs with completed active primary treatment within the
past 36 months
52.6 ± 10.7
PE: 22%, MS: 9%, Cop: 7%, Inf: 30%
Edib et al. [54]
2016
Malaysia
Cross-sectional
SCNS-SF34
117
BCSs at all ages and any stages and had survived at least one year after diagnosis
38.2 ± 27.2
PS: 56.5%, PE: 66.7%, FCR: 76.1%, Sex: 35%, Cop: 58.1%, Inf: 45.3%
Farrelly et al. [77]
2013
Australia
Cross-sectional
SMQ
279
BCSs who had been identified as carrying a BRCA1/2 mutation
46 ± 13.9
PE:32.9%, FCR:41.3%, FS:33.1%, Fns: 22.3%, Cop: 39.7%, Inf: 29.1%, PC: 35.5%
Fong et al. [55]
2016
Malaysia
Cross-sectional
SCNS-SF34
101
BCSs
57.9 ± 9.53
FCR: 16.8%, MS: 14.9%, Inf: 20.8%, MC: 3.2%
Shiha et al. [78]
2020
Hong Kong
China
Cross-sectional
CCSUNS
157
BCSs with survival duration 2–5 years
55.2 ± 10.6
PS: 49.7%, PE: 20.4%, FCR: 60.5%, Cop: 29.9%, Inf: 52.9%, MC: 25.8%, Dig: 21%
Shiha et al. [78]
2020
Hong Kong
China
Cross-sectional
CCSUNS
192
BCSs with survive duration over 5 years
57.34 ± 9.6
PS:18.2%, PE:15.1%, FCR:47.7%, FS:15.6%, MS:19%, Cop:10.4%, Inf:44.8%, MC:44.3%
Hwang et al. [66]
2006
Korea
Cross-sectional
SCNS
459
BCSs
NR
PE: 46.5%, MS: 53.8%, Inf: 48.8%, MC: 46.8%
Lamb et al. [56]
2011
Hong Kong
China
Cross-sectional
SCNS-SF34
348
Chinese BCSs
NR
PS: 10.6%, PE: 16%, FCR:16.4%, MS: 31.2%, Inf: 52%, MC: 52.2%
Lamb et al. [56]
2011
Hong Kong
China
Cross-sectional
SCNS-SF34
293
German Caucasian BCSs
NR
PS: 48.9%, PE: 43.6%, FCR: 57.1%, MS: 32%, Inf: 37%, MC: 35.6%
Garryc et al. [37]
2013
UK
Mixed
SMQ
101
BCSs who were currently diagnosed or attending follow-up clinics
NR
PS: 44.5%, PE: 35%, MS: 65%
Meer et al. [38]
2017
British Columbia
Cross-sectional
SMQ
132
BCSs
NR
Act:58%, MC: 64%, FCR, Inf
Mirzaei et al. [57]
2019
NR
Cross-sectional
SCNS-SF34
190
BCSs under chemotherapy and radiotherapy
NR
PS: 14.5%, PE: 31.3%, Inf: 36%
Allison et al. [39]
2021
USA
Cross-sectional
SMQ
199
BCSs who had completed primary cancer therapy
59
PS: 55%, PE: 55%, FCR: 73%
Napoles et al. [79]
2016
Spanish
Cross-sectional
Tel-survey
118
BCSs with completed treatment within 10 years
NR
PS: 29.5%, PE: 33.7%, Act: 69%, Inf: 70%
Sleight et al. [80]
2018
USA
Cross-sectional
SCNS-SF34
99
BCSs with completed primary treatment
54.0 ± 8.6
PS:39%, PE:37.5%, FCR:49%, MS: 42%, Cop:35%, Act:49.5%, Inf:43%, MC:54%
Winnie et al. [58]
2014
Hong Kong
China
Cross-sectional
SCNS-SF34
163
BCSs at one year after cancer treatment
NR
Inf: 59%
Wangd et al. [59]
2018
Chinese Mainland
Cross-sectional
SCNS-SF34
121
Rural BCSs after treatment
49.5 ± 9.7
FCR: 57.8%, MS: 46.5%, Inf: 57%, MC: 49.2%
Wangd et al. [59]
2018
Chinese Mainland
Cross-sectional
SCNS-SF34
143
Urban BCSs after treatment
49.5 ± 9.7
PE: 38.5%, FCR: 46.2%, MS: 36.4%, Cop: 47.6%, Act: 35.7%, Inf: 42%, MC: 44.1%
Annika et al. [40]
2013
Denmark
Cross-sectional
SMQ
261
BCSs during and after primary treatment for 4 months
60
Inf: 18%, MC: 15%, MS: 12%
Palmer et al. [41]
2017
NR
Cross-sectional
SMQ
103
BCSs diagnosed over 3 years
62.7
PS: 60%, Sex: 55%
Park et al. [67]
2012
Korea
Cross-sectional
SCNS
1084
BCSs at stages I, II, or III
NR
MS: 47.9%, Inf: 44%, MC: 43.7%
Park et al. [68]
2013
Korea
Cross-sectional
SCNS
52
BCSs
48.34 ± 8.3
PE:26.9%, FCR:33.1%, FS:29.6%, MS: 30.1%, Inf: 37.6%, MC:41.5%, PC: 29.6%
Silvia et al. [50]
2013
Switzerland
Cross-sectional
SMQ
175
BCSs under treatment
NR
PS: 79.6%, PE: 24.1%, Dig: 55.8%
Schmidt et al. [43]
2018
Germany
Cross-sectional
SMQ
190
BCSs survived 5 years after diagnosis
NR
PS: 37.5%, Cog: 36%
Tsunge et al. [31]
2017
Malaysia
Mixed
SCNS-SF34
259
BCSs
56.2 ± 10.3
FCR:42.9%, Act
Ellegaard et al. [70]
2017
Denmark
Cross-sectional
CaSUN
155
BCSs between three months and five years after diagnosis
63
MS: 34.8%, Inf: 22.3%, Cop: 41.3%, PS: 20%, PE: 13.5, FCR: 16.1%
Hodgkinson et al. [45]
2007
Australia
Cross-sectional
SMQ
117
BCSs diagnosed 2–10 years
61
FCR:32.7%, Inf: 28.2%, MS: 21.8%, Cop:18.5%, Fns: 19.3%, MC: 18.5%
Winnie et al. [61]
2013
Hong Kong
China
Cross-sectional
SCNS-SF34
376
BCSs completed treatment less than 1 year ago
53.8 ± 11.5
PS:7.2%, FCR:12%, PE:5.9%, Sex:3.7%, MS: 31.5%, MC: 19.1%, MS:35.9%, Inf: 30.7%
Elsousg et al. [81]
2023
Palestine
Mix
SCNS-SF34
352
BCSs
NR
PE: 63%, Inf: 62%, PS:61%, Act: 61%
Chae et al. [71]
2019
Korea
Cross-sectional
CNAT
332
BCSs
NR
PS, FCR, MS, Inf, MC
Hernández et al. [60]
2019
Mexico
Cross-sectional
SCNS-SF34
186
BCSs during adjuvant endocrine therapy
54.5 ± 10.7
PS, PE, Fns, Sex, Dig
Han et al. [44]
2019
Korea
Cross-sectional
SMQ
146
BCSs who had undergone surgery and treatment
48.53 ± 8.2
PS, PE, MS, Inf, Sex
Lee et al. [30]
2021
Korea
Cross-sectional
CNAT
426
Physicians and BCSs
NR
PE, FCR, MS, Inf, MC
Burgmann et al. [82]
2016
Germany
Cross-sectional
QSCP
88
Young BCSs aged below 40
NR
FCR, Sex, PE, fear of further hospital stays
Chowdhury et al. [62]
2022
Bangladesh
Cross-sectional
SCNS-SF34
138
BCSs
40.5 ± 10.55
Inf
Fong et al. [63]
2019
Malaysia
Cross-sectional
SCNS-SF34
259
BCSs
56.2 ± 10.29
Fns, Cop, MS, FS, SS, SP
Gálvez et al. [83]
2018
Mexico
Cross-sectional
unmet SCN
150
Young BCSs
36
Inf
Gilmore et al. [46]
2014
USA
Cross-sectional
SMQ
114
Adult BCSs for their initial survivorship
NR
PS, PE, MS, Sex
Tan et al. [47]
2015
USA
Cross-sectional
SMQ
34
BCSs
64.7 ± 12.7
Cop, Inf
Wong et al. [48]
2020
USA
Cross-sectional
SMQ
746
BCSs in the first 15 months after diagnosis
NR
Act, MC
Thewes et al. [49]
2004
Australia
Cross-sectional
SMQ
95
BCSs
NR
PE, Inf, MC
Silvia et al. [50]
2011
Switzerland
Cross-sectional
SMQ
72
BCSs
57.5 ± 11.8
PS, PE, Sex
Chengf et al. [32]
2018
Singapore
Mixed
SCNS
250
BCSs with completed treatment
54.7 ± 8.2
MS, PE, PS, Inf, Sex
Elsousg et al. [81]
2023
Palestine
Mixed
Interviews
25
BCSs
NR
MS, FS, SS, Sex, Dig
Chengf et al. [32]
2018
Singapore
Mixed
Interviews
80
BCSs with completed treatment
55.3 ± 7.6
MS, Inf, SS, FCR, Fns, Cop
Beatty et al. [84]
2008
Australia
Qualitative
Interviews
34
Early-stage BCSs within the past 12 months
53.5 ± 12.5
PS, Cog, PE, Cop
Adams et al. [85]
2017
USA
Qualitative
Interviews
15
Rural BCSs
NR
PS, Cog, PE, Cop, Inf, SP, SS
Dönmez et al. [86]
2021
Turkey
Qualitative
Interviews
19
BCSs with breast cancer-related lymphedema
52.15 ± 7.7
PS, Act, PE, SS, Inf, FS
Beaver et al. [87]
2016
UK
Qualitative
Interviews
20
BCSs with completed neo-adjuvant chemotherapy
NR
Inf, PE
Brown et al. [14]
2018
USA
Qualitative
Interviews
68
BCSs with gender minority
18–75
Cog, Sex, SS
Li et al. [88]
2014
Chinese Mainland
Qualitative
Interviews
154
BCSs who had undergone surgery
NR
Inf, PS, Sex, Dig
Cheng et al. [89]
2016
Chinese Mainland
Qualitative
Interviews
29
BCSs
NR
FCR, PS, Dig, Sex, Fns
Cheng et al. [32]
2017
Singapore
Qualitative
Interviews
60
BCSs
NR
Cop, MS, Act
Ddungu et al. [90]
2018
Uganda
Qualitative
Interviews
252
BCSs with metastatic breast cancer
NR
PS, Act, Inf, Cog, MS, PE, Cop, Dig
Dsouza et al. [91]
2018
India
Qualitative
Interviews
17
BCS
NR
Fns, Inf, Dig, Act, FS, PE, MC
Enzler et al. [92]
2019
USA
Qualitative
Interviews
37
BCSs received or receiving treatment
NR
Cop, Inf
Lindsey et al. [93]
2016
USA
Qualitative
Interviews
41
BCSs
NR
MS, Dig, SS, PE
Hubbeling et al. [94]
2018
USA
Qualitative
Interviews
25
Young BCSs
37–53
PE, Dig, SS, FS, Inf
Keesing et al. [95]
2019
Australia
Qualitative
Interviews
26
BCSs and partners
NR
PS, FCR, SS, Sex
Landmark et al. [96]
2008
Norway
Qualitative
Interviews
7
Newly diagnosed BCSs
NR
Inf, PE, SS
Garryc et al. [37]
2013
UK
Mixed
Interviews
7
BCSs who were currently diagnosed or attending follow-up clinics
NR
MS
Oxlad et al. [97]
2008
Australia
Qualitative
Interviews
10
BCSs following primary treatment
36–68
PE, PS, Sex, FCR, Fns
Nápoles et al. [98]
2017
USA
Qualitative
Interviews
34
BCSs
NR
PS, SS, PE, MS, Inf, FCR
Tanjasiri et al. [99]
2011
USA
Qualitative
Interviews
20
BCSs
NR
Inf, SS, SP
Tsunge et al. [31]
2017
Malaysia
Mixed
Interviews
9
BCSs
56.2 ± 10.3
Cop, SS, SP
Pembroke et al. [100]
2020
USA
Qualitative
Interviews
17
BCSs previously
treated with radiation therapy
50
PE, Fns, MS, SS, Dig, Sex, Inf
Ruddy et al. [101]
2013
USA
Qualitative
Interviews
36
Young BCSs
18–42
Dig, Inf, PS, SS, Cop
Ruddy et al. [102]
2015
USA
Qualitative
Interviews
20
Young BCSs
 > 42
Dig, FS
BCSs breast cancer survivors, CSUNQ Cancer Survivors Unmet Needs Questionnaire, SCNS Supportive Care Needs Survey, SCNS-SF34 The Short-form Supportive Care Needs Survey questionnaire, SCNS-Breast Supportive Care Needs Survey-Breast Cancer, CaSUN Cancer Survivors Unmet Needs Survey, CaSUN-S Spanish Version of the Cancer Survivors' Unmet Needs, CSP-BC Cancer Survivor Profile-Breast Cancer, HNA Holistic Needs Assessment, EPR electronic patient record, MCCC-CSSN Mayo Clinic Cancer Centre's Cancer Survivors Survey of Needs, CNAT The Comprehensive Needs Assessment Tool, SCN The unmet supportive care needs, SMNAI Survivors Module Needs-Assessment Instrument, CCSUNS Chinese Cancer Survivors' Unmet Needs Scale, QSCP Questionnaire on Stress in Cancer Patients; unmet SCN: unmet supportive care needs, SMQ Self-made questionnaire, PS Physical/symptom, PE Psychological/emotional, FCR Fear of cancer recurrence/ spreading, FS Family support, MS Medical support, SS Social support, Fns Financial support, Sex sexual/intimacy, Cop Coping/survival, Act Daily activity, SP Spiritual support, Inf Information support, MC Medical counseling, PC Peers communication, Cog Cognitive needs, Dig Dignity, NR not clearly, a, b, d, different population in the same study (a, survived < 5 years vs survived > 5 years; b, Chinese vs German; d, rural population vs urban population); c, e, f, g: mixed study, the quantitative and qualitative sections were listed separately

The estimated prevalence of USCNs from quantitative studies

The quantitative synthesis evaluating the proportion of USCNs in each domain were listed in Table 2. The most proportion of USCN was focused on social support (74%), daily activity (54%), sexual/intimacy (52%), fear of cancer recurrence/ spreading (50%), and information support (45%). However, the point estimate for social support should be interpreted with enough caution for they were extracted from two studies, which were highly inconsistent in their estimates [90.9% versus 52%]). The pooled estimate was based on a small sample, and the heterogeneity was large (I2 = 100%). There were amounts of studies that were excluded without the full text, which also may be one source of risk of bias.
Table 2
Estimated prevalence of USCNs by domains
Domain
No. of studies
Total N
Pooled proportion (%)
95% CI
I2 (%)
SS
2
1750
0.74
0.73,0.76
100
Act
11
2523
0.54
0.52,0.56
87
Sex
9
2556
0.52
0.52,0.56
99
FCR
24
5916
0.50
0.40,0.60
98
Inf
33
8352
0.45
0.37,0.52
98
PS
28
8346
0.43
0.32,0.54
100
PE
33
9814
0.42
0.33,0.5
100
Dig
4
1734
0.42
0.4,0.44
99
PC
3
533
0.38
0.34,0.42
60
MS
24
7803
0.36
0.27,0.44
99
Cog
4
2565
0.36
0.35,0.38
100
FS
9
2218
0.34
0.09,0.59
100
Cop
15
2521
0.34
0.24,0.44
98
MC
23
7223
0.33
0.32,0.34
99
SP
3
1285
0.32
0.3,0.33
100
Fns
5
2825
0.24
0.2,0.5
99
PS Physical/symptom, PE Psychological /emotional, FCR Fear of cancer recurrence/ spreading, FS Family support, MS Medical support, SS Social support, Fns Financial support, Sex sexual/intimacy, Cop Coping/survival, Act Daily activity, SP Spiritual support, Inf Information support, MC Medical counseling, PC Peers communication, Cog Cognitive needs, Dig Dignity

Frequency of unmet needs

By calculating the frequency of unmet domains (Fig. 4), information need (55) and psychological/emotional need (52) were been found to appear most frequently, followed by physical/symptom (43) medical support (35), and fear of cancer recurrence/ spreading (32).

Prominent needs lists of each domain

The prominent needs with the median proportion of each domain were listed in Table 3. In physical/symptom domain, the frequently reported needs were lack of energy/tiredness [53.6% (10.6%-88.8%)], fatigue [51% (23%-87.7%)], pain [45.5% (18.5%-66%)], sleep disorder [44.9% (14%-57%)], and hot flashes [43% (23%-100%)]. In the psychosocial/emotional domain, the frequently reported needs were learning to feel in control of your situation [58.2% (47.9%-64.1%)], worrying that the results of treatment are beyond your control [54% (16.7%-71.8%)], concerns about the worries of those close to you [51.2% (43.4%-97.8%)], keep a positive outlook [49% (37%-53.8%)], and anxiety [48.7% (16%-90.6%)]. Fears of cancer spreading [57.5% (16.4%-80.3%)] and fear of cancer recurrence [47.9% (28.6%-73%)] play the predominant part in the fear of cancer recurrence/ spreading domain. Help to know how to support my family/ partner was the greatest USCN (85.2%) in family-related support. In the medical support field, the frequent USCNs were ongoing medical service [63%(37.4%-74.5%)], nutritional/diet needs [58%(28.4%-74)], wished to be able to obtain medical service in a quick and easy way when in need [50.9%(43.7%-85.5%)], reassurance by medical staff that the way you feel is normal [39.8% (30.8%-43%)], and hospital staff acknowledging, showing sensitivity to your feeling and emotion needs [38% (28.2%-48.8%)]. Help to handle the topic of cancer in social/work situations [53.5%(50.4%-90.9%)] was the highest USCN in social support. Diminished sexual activity/sexual drive was unveiled to be the prime unmet need in the interpersonal/intimacy/sexual support field. In survival/coping needs help to make new relationships (94%), dealing with my belief that nothing bad will happen again (85.2%), and dealing with the impact of cancer on my relationships (84.6%) were the prominent USCNs. Exercise need was the most mentioned in daily activity. Help with my spiritual beliefs counted 66%(40%-92%) in spiritual need. In health system/information, up to date understandable information about your cancer and treatment [62.5%(31.4%-89.5%)], being informed about cancer which is under control or diminishing (i.e., remission) [54.1%(20.8%-76.5%)], information related to hereditary of disease [52.5%(52.1%-52.9%)], and being informed about things you can do to help yourself to get well [51%(14.9%-80.9)] were the most pointed unmet needs. To have one member of the hospital staff with whom you can talk to about all aspects of your condition, treatment, and follow-up [45.5%(34.9%-87.7%)], spent time for discussing disease [45.3%(31.8%-63.2%)], and having access to professional counseling (e.g., psychologist, social worker, counselor, nurse specialist) if you, family, or friends need it [43.9%(27.7%-82%)] were mainly indicated in medical counseling. Talk to others who have been through a similar experience counted the most [40.4%(29.6%-87%)] in peers’ communication. Cognitive needs counted 37.8% [37.8%(36%-39.5%)]. Help to adjust to changes to the way I feel about my body (82.1%) was the primary issue in dignity needs.
Table 3
Prominent needs lists of each domain
Domain of needs
List
Median Proportion (min–max)
Physical/
symptom
• Lack of energy/tiredness
53.6% (10.6%-88.8%)
• Fatigue
51% (23%-87.7%)
• Pain
45.5% (18.5%-66%)
• Sleep disorder
44.9% (14%-57%)
• Hot flashes
43% (23%-100%)
• Osteoporosis/bone health
39% (37%-70.5%)
• Numbness/tingling in hands/feet
35% (11%-41%)
• Impairment of memory
33.1% (21%-48%)
• Change in appetite
32.4%
• Changes in weight
32% (10%-60%)
• Dry: vaginal dryness, dry/itchy skin, dry nose/mouth
29% (11%-30%)
• Manage side effects and complications of treatment
29.9% (3.5%-53.4%)
• Constipation
24.3% (21.7%-26%)
• Others: physical performance (39%), health problems regarding the breast (54%), reproductive system (58.2), urination changes (21%), and shortness of breath (21%)
 
Psychosocial/emotional
• Learning to feel in control of your situation
58.2% (47.9%-64.1%)
• Worry that the results of treatment are beyond your control
54.4% (16.7%-71.8%)
• Concerns about the worries of those close to you
51.2% (43.4%-97.8%)
• Keep a positive outlook
49% (37%-53.8%)
• Anxiety
48.7% (16%-90.6%)
• Feeling of uncertainty
46.2% (15.2%-92%)
• Nervousness
44.6% (23%-66.1%)
• Feeling down or depressed
44% (10%-82%)
• Feelings about death and dying
42.2% (39%-68.4%)
• Stress
35.6% (16.7%-77.5%)
• Reassurance that the way you feel about your risk is normal
28.9%
• Dealing with the loss of family members who had breast cancer
27.5%
• Fears about physical disability or deterioration
26.9% (24%-42.4%)
• Loss of interest in usual activities
24%
• Dealing with feelings of isolation
22.4%
• Emotional support
25% (15.1%-80.3%)
• Changes to beliefs
4.5% (3.2%- 5.7%)
Fear of cancer recurrence/ spreading
• Fears cancer spreading
57.5% (16.4%-80.3%)
• Fear of cancer recurrence
47.9% (28.6%-73%)
• Dealing with the impact that having a faulty gene has had on your family
41.3%
• Fear of further hospital stays
No data
Family support
• Help to know how to support my family/ partner
85.2%
• Talking to other family members about having a faulty cancer protection gene
37.4%
• Family or friends to be allowed with you in the hospital whenever you want
29.6%
• Talking to your children about their cancer risk
28.8%
Medical support
• Ongoing medical service
63% (37.4%-74.5%)
• Nutritional/diet needs
58% (28.4%-74%)
• Wished to obtain medical service in a quick and easy way when in need
50.9% (43.7%-85.5%)
• Reassurance by medical staff that the way you feel is normal
39.8% (30.8%-43%)
• Hospital staff acknowledge, show sensitivity to your feeling and emotion needs
37% (28.2%-48.8%)
• Hospital staff attending promptly to your physical needs
35.7% (27.3%-47%)
• My doctors to talk to each other to coordinate my care
35.3% (9.6%-79.8%)
• Being treated like a person not just another case
34.2% (25.6%-97.8%)
• Feeling reassured that the best medical care is given
33.1% (9%-87.7%)
• Being treated in a hospital(clinic) that is as physically pleasant as possible
32.9% (14.9%-41.9%)
• To feel I can manage my health together with my health team
15.6% (8.9%-85%)
Social support
• Help to handle the topic of cancer in social/work situation
53.5% (50.4%-90.9%)
Financial support
• Financial strain/difficulties
26.2% (0.2%-48.5%)
• Dealing with insurance issues that arise from having a faulty cancer protection gene
22.3%
Sex/intimacy
• Diminished sexual activity/sexual drive
70.7% (55%-86.3%)
• Changes in sexual relationship
33.3% (19%-35%)
• Change in sexual feeling
29% (25%-38.5%)
Coping/survival
• Help to make new relationships
94%
• Help to deal with the impact of cancer on my relationships
84.6%
• Help to make my life count
84.2%
• Help to move on with my life
82.2%
• Help to make decisions about my life in uncertain times
82.1%
• Help to cope with others' expectations of me as a survivor
78.6%
• Help with others not acknowledging the impact cancer has had on your life
60% (36.8%-83.2%)
• Feeling unwell a lot of the time
51.3% (37%-97.8%)
• Help to deal with my belief that nothing bad will happen again
41.5% (18.7%-87.2%)
• Deciding how best to manage increased cancer risk
39.7%
• Learning to feel in control of your situation
33%
• Help manage household responsibility
31%
• Adjust to changes in your life as a result of cancer
26.7%
• Instrumental (practical) support
19.8(7%-32.5%)
Daily activity
• Exercise
69%
• Physical activity to decrease the risk of recurrence or improve survival
55.6% (53.1%-63%)
• Yoga/meditation
55%
• Not being able to do the things you used to do
50% (29.1%-98.6%)
• Work around the home
44.9% (39.3%-59.8%)
Spiritual support
• Help with my spiritual beliefs
42% (40%-92%)
Information support
• Up to date understandable information about your cancer and treatment
62.5% (31.4%-89.5%)
• Being informed about cancer that is under control or diminishing (i.e., remission)
55.3% (20.8%-76.5%)
• Information related to hereditary disease
52.5%(52.1%-52.9%)
• Being informed about the things you can do to help yourself to get well
51% (14.9%-80.9)
• Being given explanations on those tests about which you would like to get explanations
47% (29.7%-92%)
• Being informed about your test results as soon as feasible
44.9% (20.8%-59.8%)
• Being given information (written information, diagrams, and drawings) about aspects of managing your illness and side effects at home
44.2% (18.8%-73.5%)
• Being given written information about important aspects of your care
44.2% (31.9%-97.1%)
• Being adequately informed about the benefits and side effects of therapy before you choose to have them
41.5% (24.8%-91.3%)
• Information resources
33.6% (28.7%-38.5%)
• Information relevant to my partner/family
32.5% (28.1%-92.7%)
• To be given choices about when to go in for tests or treatment
30.3%
• Obtain information to help manage increased cancer risk
29.7%(29.1%-34.7%)
• More choice about which cancer specialists you see
29.3% (19.3%-45.3%)
• Be given information about sexual relationship
27.8% (19%-33.3%)
• More choice about which hospital you attend
25.3% (21.4%-31.6%)
• Patient education: diet:19%, relaxation/meditation: 18%, physical activity: 10%
 
Medical
counseling
• To have one member of the hospital staff with whom you can talk to about all aspects of your condition, treatment, and follow-up
45.5% (34.9%-87.7%)
• Spent time discussing disease
45.3% (31.8%-63.2%)
• Having access to professional counseling (e.g., psychologist, social worker, counselor, nurse specialist) if you, family, or friends need it
43.9% (27.7%-82%)
• Spent time listening to feelings
31.5% (19.7%-43.2%)
• Counselling: psychologist or psychiatrist: 15.5%(15%-16%), financial and occupational:15%
 
Peers communication
• To talk to others who have been through a similar experience
40.4% (29.6%-87%)
• Talking with other women who have faulty cancer protection gene
36%
• Finding someone who understands your situation
32.3% (29.6%-35%)
Cognitive needs
• Cognitive needs
37.8% (36%-39.5%)
• Memory or concentration problems
10%
Dignity
• Help to adjust to changes in the way I feel about my body
82.1%
• Body image perception
38.4(8.9%-59.5%)

Synthesis of unmet needs in qualitative studies

A content analytic approach was conducted to synthesize USCNs and categorize them into different domains. The result of the synthesis was listed in Table 4. In family support, participants not only expressed the need for support from family members but also presented the need in supporting their family members, which was in agreement with the result from quantitative research. In dignity, except for an unmet need in body image, more needs regarding disease disclosure were also expressed.
Table 4
Synthesis of unmet needs in qualitative studies
Domain of needs
Lists
Physical/symptom
Coping with side-effects [84, 97]
Symptom management needs (pain, nutrition and diet, wound management, fatigue) [32, 85, 8890, 95, 97]
Psychosocial/emotional
Stress and adjustment reactions [84], challenges resuming roles [98]
Emotional support and empathy [32, 87]
Sensitivity to feelings [90], sense of abandonment [98]
Fertility concerns [94]
Apprehension/uncertain/negativity about the future [86, 97], positive outlook [90]
Fear of cancer recurrence
Fear of recurrence [32, 89, 95, 97, 98]
Family support
Recognition and support from family/friends/partners [14, 91, 98]
Lack of support services for cancer caregivers [93]
Caregiver burnout [90]
Appropriate support for their family and partners [14, 102]
Medical support
Attention from healthcare professionals [86]
Continuity of care [32], the formal transition from active treatment to survivorship [98, 101]
Pleasant environment, inadequate hospital amenities and medicines [90]
Availability of anticancer therapy, affordability of healthcare [81]
Social support
Strong social support networks [85, 93, 94] social difficulties [85]
A culture that discourages the discussion of cancer or culturally appropriate cancer resources [93]
Financial support
Financial burden/ cost of care [8991], limited funding [90, 97]
Financial well-being [32]
Sex/intimacy
Impact of treatment/restriction/alteration in a sexual relationship and intimacy [14, 85, 89, 95, 97]
Coping/survival
Manage others' unhelpful beliefs, expectations, and emotions [84]
Issues with survival and growth [84, 85]
Barriers to employment during survivorship [94, 95]
Approaches to post-treatment care (Infrequent clinical follow-ups, long distances to travel) [32]
Daily activity
Difficulties in performing household chores [86, 91], self-care activities, and shopping [86]
Spiritual support
Religion and spirituality [85, 90, 99]
Information support
Survivorship education and self-management [32, 85, 101]
Lifestyle advice [32, 86, 90]
Information about disease [88], side effects of treatment [98], and treatment plan [90]
Available access to healthcare sources and choice of cancer specialists [37, 86, 90]
Medical counseling
Counseling [90, 91]
Appropriate counselors [101]
Peers communication
Connecting with other survivors (patients) and caregivers [93, 101, 102]
Dignity
Dealing with self-concept change [84]
Persistence of body image disturbance [88, 89, 94]
Difficulty in disclose [90], and keeping their cancer a secret [85]
Treatment with dignity and respect for a patient's opinion [90]
It was found that USCNs were significantly associated with many factors such as age, education, symptoms, treatment, stress, anxiety, and so on (Table 5), which could be summarized into three main aspects: demographic factors, disease factors, and psychological factors. Variables significantly associated with higher USCNs across all domains (psychological, health system and information, physical and daily living, patient care and support, and sexual) were indeterminate in age, marriage, occupational status, family income, level of education, and treatment time. The determinable single relationship was discovered in rural residents, short duration, combined treatment, advanced disease stage, poor performance status, higher depression, higher stress, higher distress, higher anxiety, poor QoL, symptoms severity, more comorbidity, and physical impairment.
Table 5
Risk factors related to USCNs
 
All domain
Sexuality
Information
Psychology
Physical/daily life
Patient care
Age
 Young age
( +) [31, 40, 63, 64, 69, 73, 81]
( +) [51, 66]
( +) [66]
   
 Old age
( +) [61]
 
( +) [103]
 
( +) [71]
 
Marriage
 Married
( +) [62, 81]
( +) [31, 6264]
    
 Unmarried
( +) [40]
   
( +) [31, 63]
 
Occupation
 Employed
( +) [31, 63, 73]
    
( +) [62]
 Unemployed
( +) [51]
 
( +) [71]
   
Rural resident
( +) [59]
 
( +) [59]
   
Short duration since diagnosis
( +) [31, 51, 59, 63, 67, 73, 81]
 
( +) [67]
( +) [67, 76]
( +) [76]
 
Family income
 Good
( +) [57]
     
 Poor
( +) [73]
     
Level of education
 Low
( +) [59]
 
( +) [62]
( +) [66, 68]
( +) [66, 68]
 
 High
( +) [31, 40, 63]
 
( +) [32]
( +) [32]
 
( +) [66]
Treatment time
 Being under treatment
( +) [31, 74]
( +) [62]
(-) [75]
  
( +) [62]
 Have completed treatment
( +) [62, 73]
( +) [103]
(-) [32]
( +) [32, 76]
( +) [66, 76]
( +) [75]
Treatment method
 Single
   
( +) [76]
 
( +) [62]
 Combined
( +) [73]
( +) [103]
(-) [62]
  
( +) [62]
Advanced disease stage
( +) [31, 51, 59, 61, 63, 73]
     
Poor performance status
( +) [51]
  
( +) [68]
( +) [68]
 
Higher depression
( +) [42, 49, 67, 104, 105]
  
( +) [68, 105]
( +) [105]
 
Higher stress
( +) [71]
( +) [56]
    
Higher distress
( +) [42, 103, 106]
 
( +) [56]
( +) [56]
( +) [56]
 
Higher anxiety
( +) [40, 42, 45, 49]
 
( +) [15]
( +) [105]
 
( +) [56]
Poor QoL
( +) [60, 67, 106]
  
( +) [61]
( +) [61]
( +) [61]
Symptoms severity
( +) [52, 69]
( +) [56]
( +) [56]
( +) [56]
( +) [56, 60]
( +) [56]
Comorbidity
( +) [49]
   
( +) [71, 103]
 
Physical impairment
( +) [42, 73]
     
Others
Level of survivorship concerns ( +) [104]
Perception of illness ( +) [57]
Family history of cancer ( +) [73]
Social impairment ( +) [42]
Having children less than two ( +) [62]
Larger tumor size (> 2 cm) ( +) [66]
Relapse and terminal care patients ( +) [75]
The group with thoughts of suicide ( +) [71]
Invasive breast cancer ( +) [62]
( +) Positive correlation, (-) Negative correlation

Discussion

From the cancer genomic revolution, and new inroads in immunotherapy for breast cancer to unique concerns of quality of life as well as survivors’ issues, these works represent much of the promise of breast cancer research as well as the challenges in the coming years [107]. There is a huge burden of supportive care needs among BCSs that are still under management, such as psychosocial issues [108], sexuality [109], information [110], and symptoms burden [111]. Most authors have investigated the USCNs among BCSs [112, 113] through cross-sectional study or qualitative interview. However, to our knowledge, few researchers conducted evidence synthesis [23, 114]. This scoping review aimed to explore the breadth and depth of existing literature on USCNs among BCSs, with the goal of obtaining an in-depth understanding of this topic. Overall, this scoping review identified 77 primary studies evidencing the USCNs of breast cancer survivors. The aims are trying to inform the prominent needs as well as influence factors, to provide guidelines for conveying superior cancer care.

Quality appraisal

The results of the quality assessment of the involved research were presented in Figs. 2 and 3. The overall studies demonstrated a low to moderate risk of bias. It showed sufficient quality in terms of research method, data collection, and analysis. For quantitative research, there was an overall low risk of bias in sample size and appropriate sample frame. However, a high risk of bias was found in the detailed description of the study subjects and setting (44.2%), and how the participants were sampled (42%). The most used instrument was the self-made questionnaire and measurement heterogeneity were due to the use of unvalidated instruments. In the qualitative studies, the overall low risk of bias was found in conclusion drawing, ethical reporting, and representativeness of data. However, a high risk of bias was related to missing statements locating the researcher culturally or theoretically (79%), and the absence of stated philosophical perspective (54%).

Assessment of USCNs

Many instruments are available to assess USCNs in breast cancer survivors. The most used instrument was the self-made questionnaire. Substantial heterogeneity was existing in their categories, development, and quality. The Short-form Supportive Care Needs Survey questionnaire (SCNS-SF34) was widely used in evaluating the need for supportive care among cancer patients with verified validity and reliability [115, 116]. However, the standardized assessment tools that are specific to people with breast cancer and their unique USCNs are absent. In our review, only Supportive Care Needs Survey-Breast Cancer (SCNS-Breast) [15] and Cancer Survivor Profile-Breast Cancer (CSP-BC) [73] were designed specifically for breast cancer patients. Meanwhile, few instruments covered all of the measurement properties [117]. Various unmet needs evaluation tools become problematic as domains assessed in our review often include psychological aspects, patient care and support, physical aspects and daily living, health system information, and sexuality [118], resulting in spiritual, social, and concerns for family or financial needs were under revealed. Besides, under most circumstances, the methodological quality was variable. In addition, dimension classifications of USCNs differ between instruments, which complicates comparisons within the literature. An urgent demand for a more specific instrument with universal applicability for BCSs should be emphasized. Meanwhile, qualitative research had provided some points that quantitative studies did not obtain. Compared to the fixed items, qualitative research provides a more flexible approach to expressing subjective experiences. Thus, the results of qualitative studies should serve as a meaningful reference for the construction and development of more specific evaluation tools.

Prevalence of USCNs

Through making a comprehensive analysis of literature and summarizing them, 16 domains of USCNs were finally identified: physical/symptom need, psychological/emotional need, fear of cancer recurrence/ spreading, family support, medical support, social support, financial support, sexual/intimacy need, coping/survival need, daily activity need, spiritual support, information support, medical counseling, peer communication, cognitive needs, and dignity. This classification is more detailed, specific, and diversified than most previous studies [118120], which could be helpful in clearly figuring out the definite unmet needs. In addition, extra USCNs were observed in concerns on caregiver burnout through qualitative studies, which indicated a need for appropriate support for their family/ caregiver/ partners. By estimating the pooled prevalence of USCNs from quantitative studies, it was found that social support (74%) counted the most proportion. However, with a small number of studies and large heterogeneity, caution must be applied as the findings might not be applicable to most breast cancer survivors. Even so, social support is still an indispensable part of BCSs. It was suggested that social support was significantly associated with resilience, posttraumatic growth [121], quality of life [122] and affective-cognitive symptoms [123]. Some social determinants such as poverty, lack of education, neighborhood disadvantage, racial discrimination, lack of social support, and social isolation were proven to significantly affect breast cancer incidence, stage at diagnosis, and survival [124]. In the present study, breast cancer patients commonly face unmet needs regarding social support in “help to handle the topic of cancer in social/work situation”, “a culture that discourages the discussion of cancer or culturally appropriate cancer resources”, “strong social support networks”, “social difficulties”. In the dignity domain, disease disclosure was also conveyed. It could be speculated that BCSs require adequate social support to in favor of their discussion and expression of the disease.
Daily activity (54%), sexual/intimacy (52%), fear of cancer recurrence/ spreading (50%), and information support (45%) were regarded as the top USCNs with high estimated prevalence. Information needs, psychological/emotional needs, physical/ symptom, medical support, and fear of cancer recurrence/spreading were been found to appear most frequently. In conclusion, fear of cancer recurrence/spreading and information need was the most reported with high pooled proportion and reporting frequency. Similarly, some previous studies have demonstrated that addressing recurrence concerns (80%) was the most commonly required [125]. Hypermutation occurs in 5% of all breast cancers with enrichment in metastatic tumors [126]. Fear of cancer recurrence (FCR) could be a powerful determinant of physical symptoms [127], psychological distress [128] and quality of life [129]. Our study demonstrated that BCSs not only faced the huge USCNs in FCR regarding “fears cancer spreading/recurrence”, but also in “dealing with the impact that having a faulty gene has had on your family”. It is not strange that the FCR is similarly reflected in the high information need related to hereditary disease. Psychological interventions might be an effective solution. A recent systematic review has recommended mindfulness and acceptance therapy-based interventions and short-term interventions to alleviate FCR [130]. Interventions to alleviate excessive worries and enhance feelings of personal control might help prevent or reduce related FCR [131].
Information needs were proved to be the most important concern among the diverse USCNs of cancer survivors [113]. Among BCSs, anxiety related to inadequate information support is common. A recent systematic review revealed that patients with breast cancer showed a huge enthusiasm in engaging intervention related to disease-focused information [132]. The prominent needs in the information domain vary among diverse patient groups. Patients with hematological malignancies were found to be mostly concerned about obtaining information about their future condition [9]. Meanwhile, more information about diet/nutrition in the form of a pamphlet or by a hospital dietician, and more information about the long-term self-management of symptoms and complications at home were discovered in patients with colon and/or rectum cancer [10]. A systematic review and synthesis of breast cancer patients' information needs developed a thorough information need model, including 3 themes, 19 categories, and 55 concepts [133]. In the present scoping review, “up to date understandable information about cancer and treatment”, “being informed about cancer which is under control or diminishing (i.e., remission)”, and “information related to hereditary disease” were the most stressed information need. Information needs regarding survivorship education, self-management, lifestyle advice and available access to healthcare sources, and choice of cancer specialists were also expressed. It inspired us to give more consideration in incorporating these unmet information needs into health education practice when delivering care for patients with breast cancer. It is believed information provision on BCSs could improve quality of life, reduce anxiety and increase intention to adhere to treatment recommendations [134]. American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline has recommended that primary care clinicians should assess the information needs of breast cancer patients and its treatment, adverse effects, other health concerns, and available support services, and should provide or refer survivors to appropriate resources to meet these needs [135]. Technology-based or web-based seems to be an effective approach to provide enough information aid [136, 137]. Bootsma et al. integrated their investigation results about unmet information needs into a user-centered design to develop an informative website that targeted men with breast cancer [13].
Sexuality and intimacy represent a pillar of quality of life. The vast amount of evidence exists showing that cancer dramatically impacts a woman’s sexuality, sexual functioning, intimate relationships, and sense of self [138]. The overall prevalence of sexual dysfunction among female cancer survivors ranged from 16.7 to 67% [139]. Currently, sexual trouble is becoming more prevalent in BCSs owing to breast absence led by surgical treatment, body image, and adjuvant hormones. Low sexual desire persists throughout the timeline of BCSs, from BC diagnosis to after treatment [140]. Patients suffer from hot flashes, difficulty sleeping, loss of libido and intimacy, all resulting in significant morbidity and loss of quality of life [141]. The current finding exhibited that BCSs faced a majority of unsolved sexuality issues, particularly in diminished sexual activity/sexual drive, changes in sexual relationships and sexual feelings. A similar study conducted in gynecological cancer survivors revealed that they faced most sexual concerns on decreased sexual activity, emotional distancing from the partner, anxiety, and depression related to sexual performance [142, 143]. Among female cancer survivors, dyspareunia was the main type of sexual dysfunction reported after diagnosis [139]. Although, sexual issues are often neglected and not appropriately addressed by healthcare providers in their routine practice, which remains an unmet need with remarkable effects on general health and quality of life [144]. Effective communication between the health care professionals and cancer survivors was recommended to overcome this problem [139]. A review of the literature revealed trends utilizing psychoeducational interventions that include combined elements of cognitive and behavioral therapy with education and mindfulness training, which has positive effects on arousal, orgasm, satisfaction, overall well-being, and decreased depression [141].

Factors associated with USCNs

Our present review showed that USCNs were significantly associated with demographic data, social determinants, disease status, quality of life, performance status, and some psychological indicators. However, causality cannot be determined due to the cross-sectional nature of the included studies. Meanwhile, due to the heterogeneity of research design, participation, and setting, a positive predictor in one article may be negative in another. Short duration since diagnosis, advanced disease stage, poor performance status, higher depression, higher stress, higher distress, anxiety, poor quality of life, more symptoms severity, existing comorbidity, and physical impairment, were identified to be significantly associated with higher USCNs of nearly all domains in most research. Compared to longer duration, a short duration since diagnosis might means more inadaptation no matter in physical or psychological or other aspects. As many studies had showed [70, 145, 146], high psychological issues, physical status, and poor quality of life were the strong predictive factors of high USCNs in BCSs. Patients who are assessed as high-risk need should be paid more attention in practice. Hence, the implementation of standardized screening tools in any phase of disease trajectory should be conducted for timely identification and intervention. In addition, prospective studies are needed to verify influencing factors that have a causal relationship with USCNs.

Limitations and future directions

To the best of our knowledge, this study is the first and most comprehensive systematic scoping review regarding USCNs among breast cancer survivors. Firstly, through making a comprehensive analysis of literature and summarizing, a total of 16 domains of USCNs were finally identified. This classification is more detailed, specific, and diversified than most previous studies. Secondly, the most unmet supportive care needs were identified and the prominent needs lists of each domain were exhibited meticulously with proportion, through which the reader could obtain an in-depth understanding of USCNs among the breast cancer population. Thirdly, a comprehensive vision was provided to know potential influencing factors to USCNs for most of them were presented synthetically.
Even though, our study has some limitations. One of the limitations is the inclusion of literatures that are published only in English. In addition, there were amounts of studies without the full text. These may result in the exclusion of potentially useful research. What’s more, we failed to perform subgroup analysis because of the complexity and heterogeneity of the incorporated breast cancer population.
Research about USCNs among BCSs in more detailed classifications are needed to provide targeted supportive care, there is a need for more comparations among breast cancer patients in different subgroups. Also, an urgent demand for a more specific instrument with universal applicability for BCSs should be emphasized due to the heterogeneity of assessment tools. What’s more, we summarized the risk factors of unmet needs but failed to analyze the odds ratio (OR), hazard ratios (HRs), or relative risk (RR) of each variable. Data synthesis through meta-analysis or prospective study to determine the real factors are demanded.

Conclusion

BCSs are experiencing the highest USCNs in fear of cancer recurrence, daily activity, sexual/intimacy, psychology, and information field. Various risk factors had been discovered to correlate with USCNs. Factors that have a causal relationship with USCNs should be identified through synthesizing longitudinal studies. There was substantial heterogeneity in study populations and assessment methods warranting future investigation considering specific samples and standard USCNs assessment tools that are validated for use in BCSs. Meanwhile, effective interventions based on guidelines should be formulated and conducted to decrease USCNs among BCSs in the future.

Acknowledgements

We are grateful to the participating patients and to all other co-investigators who contributed to this study.

Declarations

This is a systematic scoping review. The Ethical institution has confirmed that no ethical approval and informed consent were required.
Not applicable.

Competing interests

The authors declare no competing interests..
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:9605439.PubMedPubMedCentralCrossRef Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, Zaguia A, Koundal S, Belay A. Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:9605439.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J Clin 2021;71(3):209–249. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: Cancer J Clin 2021;71(3):209–249.
3.
Zurück zum Zitat Nardin S, Mora E, Varughese FM, D’Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864.PubMedPubMedCentralCrossRef Nardin S, Mora E, Varughese FM, D’Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Grusdat NP, Stäuber A, Tolkmitt M, Schnabel J, Schubotz B, Wright PR, Schulz H. Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. Support Care Cancer. 2022;30(5):3733–44.PubMedPubMedCentralCrossRef Grusdat NP, Stäuber A, Tolkmitt M, Schnabel J, Schubotz B, Wright PR, Schulz H. Routine cancer treatments and their impact on physical function, symptoms of cancer-related fatigue, anxiety, and depression. Support Care Cancer. 2022;30(5):3733–44.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Shamieh O, Alarjeh G, Li H, Abu Naser M, Abu Farsakh F, Abdel-Razeq R, et al. Care needs and symptoms burden of breast cancer patients in Jordan: a cross-sectional study. Int J Environ Res Public Health. 2022;19(17):10787. Shamieh O, Alarjeh G, Li H, Abu Naser M, Abu Farsakh F, Abdel-Razeq R, et al. Care needs and symptoms burden of breast cancer patients in Jordan: a cross-sectional study. Int J Environ Res Public Health. 2022;19(17):10787.
6.
Zurück zum Zitat Lovelace DL, McDaniel LR, Golden D. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019;64(6):713–24.PubMedCrossRef Lovelace DL, McDaniel LR, Golden D. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019;64(6):713–24.PubMedCrossRef
7.
Zurück zum Zitat Roziner I, Perry S, Dahabre R, Bentley G, Kelada L, Poikonen-Saksela P, et al. Psychological and somatic symptoms among breast cancer patients in four European countries: a cross-lagged panel model. Stress Health. 2022;39(2):474–82. Roziner I, Perry S, Dahabre R, Bentley G, Kelada L, Poikonen-Saksela P, et al. Psychological and somatic symptoms among breast cancer patients in four European countries: a cross-lagged panel model. Stress Health. 2022;39(2):474–82.
8.
Zurück zum Zitat Tsai W, Nusrath S, Zhu R. Systematic review of depressive, anxiety and post-traumatic stress symptoms among Asian American breast cancer survivors. BMJ Open. 2020;10(9):e037078.PubMedPubMedCentralCrossRef Tsai W, Nusrath S, Zhu R. Systematic review of depressive, anxiety and post-traumatic stress symptoms among Asian American breast cancer survivors. BMJ Open. 2020;10(9):e037078.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Tsatsou I, Konstantinidis T, Kalemikerakis I, Adamakidou T, Vlachou E, Govina O. Unmet supportive care needs of patients with hematological malignancies: a systematic review. Asia Pac J Oncol Nurs. 2021;8(1):5–17.PubMedCrossRef Tsatsou I, Konstantinidis T, Kalemikerakis I, Adamakidou T, Vlachou E, Govina O. Unmet supportive care needs of patients with hematological malignancies: a systematic review. Asia Pac J Oncol Nurs. 2021;8(1):5–17.PubMedCrossRef
10.
Zurück zum Zitat Kotronoulas G, Papadopoulou C, Burns-Cunningham K, Simpson M, Maguire R. A systematic review of the supportive care needs of people living with and beyond cancer of the colon and/or rectum. Eur J Oncol Nurs. 2017;29:60–70.PubMedCrossRef Kotronoulas G, Papadopoulou C, Burns-Cunningham K, Simpson M, Maguire R. A systematic review of the supportive care needs of people living with and beyond cancer of the colon and/or rectum. Eur J Oncol Nurs. 2017;29:60–70.PubMedCrossRef
11.
Zurück zum Zitat Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17(8):1117–28.PubMedCrossRef Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17(8):1117–28.PubMedCrossRef
12.
Zurück zum Zitat Swash B, Hulbert-Williams N, Bramwell R. Unmet psychosocial needs in haematological cancer: a systematic review. Support Care Cancer. 2014;22(4):1131–41.PubMedCrossRef Swash B, Hulbert-Williams N, Bramwell R. Unmet psychosocial needs in haematological cancer: a systematic review. Support Care Cancer. 2014;22(4):1131–41.PubMedCrossRef
13.
Zurück zum Zitat Bootsma TI, Duijveman P, Pijpe A, Scheelings PC, Witkamp AJ, Bleiker EMA. Unmet information needs of men with breast cancer and health professionals. Psychooncology. 2020;29(5):851–60.PubMedPubMedCentralCrossRef Bootsma TI, Duijveman P, Pijpe A, Scheelings PC, Witkamp AJ, Bleiker EMA. Unmet information needs of men with breast cancer and health professionals. Psychooncology. 2020;29(5):851–60.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Brown MT, McElroy JA. Unmet support needs of sexual and gender minority breast cancer survivors. Support Care Cancer. 2018;26(4):1189–96.PubMedCrossRef Brown MT, McElroy JA. Unmet support needs of sexual and gender minority breast cancer survivors. Support Care Cancer. 2018;26(4):1189–96.PubMedCrossRef
15.
Zurück zum Zitat Barr K, Hill D, Farrelly A, Pitcher M, White V. Unmet information needs predict anxiety in early survivorship in young women with breast cancer. J Cancer Survivor : Res Pract. 2020;14(6):826–33.CrossRef Barr K, Hill D, Farrelly A, Pitcher M, White V. Unmet information needs predict anxiety in early survivorship in young women with breast cancer. J Cancer Survivor : Res Pract. 2020;14(6):826–33.CrossRef
16.
Zurück zum Zitat Vreman RA, Heikkinen I, Schuurman A, Sapede C, Garcia JL, Hedberg N, Athanasiou D, Grueger J, Leufkens HGM, Goettsch WG. Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health. 2019;22(11):1275–82.PubMedCrossRef Vreman RA, Heikkinen I, Schuurman A, Sapede C, Garcia JL, Hedberg N, Athanasiou D, Grueger J, Leufkens HGM, Goettsch WG. Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health. 2019;22(11):1275–82.PubMedCrossRef
18.
Zurück zum Zitat Moghaddam N, Coxon H, Nabarro S, Hardy B, Cox K. Unmet care needs in people living with advanced cancer: a systematic review. Support Cancer. 2016;24(8):3609–22.CrossRef Moghaddam N, Coxon H, Nabarro S, Hardy B, Cox K. Unmet care needs in people living with advanced cancer: a systematic review. Support Cancer. 2016;24(8):3609–22.CrossRef
19.
Zurück zum Zitat Batehup L, Gage H, Williams P, Richardson A, Porter K, Simmonds P, Lowson E, Dodson L, Davies N, Wagland R, et al. Unmet supportive care needs of breast, colorectal and testicular cancer survivors in the first 8 months post primary treatment: a prospective longitudinal survey. Eur J Cancer Care. 2021;30(6): e13499.CrossRef Batehup L, Gage H, Williams P, Richardson A, Porter K, Simmonds P, Lowson E, Dodson L, Davies N, Wagland R, et al. Unmet supportive care needs of breast, colorectal and testicular cancer survivors in the first 8 months post primary treatment: a prospective longitudinal survey. Eur J Cancer Care. 2021;30(6): e13499.CrossRef
20.
Zurück zum Zitat Oh HM, Son CG. The risk of psychological stress on cancer recurrence: a systematic review. Cancers. 2021;13(22):5816. Oh HM, Son CG. The risk of psychological stress on cancer recurrence: a systematic review. Cancers. 2021;13(22):5816.
21.
Zurück zum Zitat Tola YO, Chow KM, Liang W. Effects of non-pharmacological interventions on preoperative anxiety and postoperative pain in patients undergoing breast cancer surgery: a systematic review. J Clin Nurs. 2021;30(23–24):3369–84.PubMedCrossRef Tola YO, Chow KM, Liang W. Effects of non-pharmacological interventions on preoperative anxiety and postoperative pain in patients undergoing breast cancer surgery: a systematic review. J Clin Nurs. 2021;30(23–24):3369–84.PubMedCrossRef
22.
Zurück zum Zitat Hart NH, Crawford-Williams F, Crichton M, Yee J, Smith TJ, Koczwara B, Fitch MI, Crawford GB, Mukhopadhyay S, Mahony J, et al. Unmet supportive care needs of people with advanced cancer and their caregivers: a systematic scoping review. Crit Rev Oncol Hematol. 2022;176: 103728.PubMedCrossRef Hart NH, Crawford-Williams F, Crichton M, Yee J, Smith TJ, Koczwara B, Fitch MI, Crawford GB, Mukhopadhyay S, Mahony J, et al. Unmet supportive care needs of people with advanced cancer and their caregivers: a systematic scoping review. Crit Rev Oncol Hematol. 2022;176: 103728.PubMedCrossRef
23.
Zurück zum Zitat Roberts C, Toohey K, Paterson C. The experiences and unmet supportive care needs of partners of men diagnosed with prostate cancer: a meta-aggregation systematic review. Cancer Nurs. 2022. Roberts C, Toohey K, Paterson C. The experiences and unmet supportive care needs of partners of men diagnosed with prostate cancer: a meta-aggregation systematic review. Cancer Nurs. 2022.
24.
Zurück zum Zitat Cochrane A, Woods S, Dunne S, Gallagher P. Unmet supportive care needs associated with quality of life for people with lung cancer: a systematic review of the evidence 2007–2020. Eur J Cancer Care. 2022;31(1): e13525.CrossRef Cochrane A, Woods S, Dunne S, Gallagher P. Unmet supportive care needs associated with quality of life for people with lung cancer: a systematic review of the evidence 2007–2020. Eur J Cancer Care. 2022;31(1): e13525.CrossRef
25.
Zurück zum Zitat Paterson C, Jensen BT, Jensen JB, Nabi G. Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: a systematic review of the evidence. Eur J Oncol Nurs. 2018;35:92–101.PubMedCrossRef Paterson C, Jensen BT, Jensen JB, Nabi G. Unmet informational and supportive care needs of patients with muscle invasive bladder cancer: a systematic review of the evidence. Eur J Oncol Nurs. 2018;35:92–101.PubMedCrossRef
26.
Zurück zum Zitat Shunmugasundaram C, Rutherford C, Butow PN, Sundaresan P, Dhillon HM. Content comparison of unmet needs self-report measures used in patients with head and neck cancer: a systematic review. Psychooncology. 2019;28(12):2295–306.PubMedCrossRef Shunmugasundaram C, Rutherford C, Butow PN, Sundaresan P, Dhillon HM. Content comparison of unmet needs self-report measures used in patients with head and neck cancer: a systematic review. Psychooncology. 2019;28(12):2295–306.PubMedCrossRef
27.
Zurück zum Zitat Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.PubMedCrossRef Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6.PubMedCrossRef
28.
Zurück zum Zitat Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.PubMedCrossRef
29.
Zurück zum Zitat Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.PubMedCrossRef Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2–10.PubMedCrossRef
30.
Zurück zum Zitat Lee I, Lee J, Lee SK, Shin H-J, Jung S-Y, Lee JW, Kim Z, Lee MH, Lee J, Youn HJ. Physicians’ awareness of the breast cancer survivors’ unmet needs in Korea. J Breast Cancer. 2021;24(1):85–96.PubMedCrossRef Lee I, Lee J, Lee SK, Shin H-J, Jung S-Y, Lee JW, Kim Z, Lee MH, Lee J, Youn HJ. Physicians’ awareness of the breast cancer survivors’ unmet needs in Korea. J Breast Cancer. 2021;24(1):85–96.PubMedCrossRef
31.
Zurück zum Zitat Tsung EJF, Lian CW. Factors contributing to unmet needs among breast cancer survivors in Kuching, Sarawak: A mixed methods study. Med J Malaysia. 2017;72:25. Tsung EJF, Lian CW. Factors contributing to unmet needs among breast cancer survivors in Kuching, Sarawak: A mixed methods study. Med J Malaysia. 2017;72:25.
32.
Zurück zum Zitat Cheng KKF, Cheng HL, Wong WH, Koh C. A mixed-methods study to explore the supportive care needs of breast cancer survivors. Psychooncology. 2018;27(1):265–71.PubMedCrossRef Cheng KKF, Cheng HL, Wong WH, Koh C. A mixed-methods study to explore the supportive care needs of breast cancer survivors. Psychooncology. 2018;27(1):265–71.PubMedCrossRef
33.
Zurück zum Zitat Baker BS, Hoffman CJ, Fenlon D. What can a third sector organisation provide for people with breast cancer that public health services cannot? Developing support services in response to service evaluation. Eur J Integr Med. 2019;30:100943. Baker BS, Hoffman CJ, Fenlon D. What can a third sector organisation provide for people with breast cancer that public health services cannot? Developing support services in response to service evaluation. Eur J Integr Med. 2019;30:100943.
34.
Zurück zum Zitat Autade Y, Chauhan G. Assess the prevalence for needs of breast cancer survivors’ in the oncology ward at a selected tertiary care hospital. J Pharmaceut Res Int. 2021;33(55A):1–12. Autade Y, Chauhan G. Assess the prevalence for needs of breast cancer survivors’ in the oncology ward at a selected tertiary care hospital. J Pharmaceut Res Int. 2021;33(55A):1–12.
35.
Zurück zum Zitat de Ligt KM, Heins M, Verloop J, Smorenburg CH, Korevaar JC, Siesling S. Patient-reported health problems and healthcare use after treatment for early-stage breast cancer. Breast (Edinburgh, Scotland). 2019;46:4–11.PubMedCrossRef de Ligt KM, Heins M, Verloop J, Smorenburg CH, Korevaar JC, Siesling S. Patient-reported health problems and healthcare use after treatment for early-stage breast cancer. Breast (Edinburgh, Scotland). 2019;46:4–11.PubMedCrossRef
36.
Zurück zum Zitat Dugan AG, Decker RE, Namazi S, Cavallari JM, Bellizzi KM, Blank TO, Dornelas EA, Tannenbaum SH, Shaw WS, Swede H, et al. Perceptions of clinical support for employed breast cancer survivors managing work and health challenges. J Cancer Survivor : Res Pract. 2021;15(6):890–905.CrossRef Dugan AG, Decker RE, Namazi S, Cavallari JM, Bellizzi KM, Blank TO, Dornelas EA, Tannenbaum SH, Shaw WS, Swede H, et al. Perceptions of clinical support for employed breast cancer survivors managing work and health challenges. J Cancer Survivor : Res Pract. 2021;15(6):890–905.CrossRef
37.
Zurück zum Zitat McGarry S, Ward C, Garrod R, Marsden J. An exploratory study into the unmet supportive needs of breast cancer patients. Eur J Cancer Care. 2013;22(5):673–83.CrossRef McGarry S, Ward C, Garrod R, Marsden J. An exploratory study into the unmet supportive needs of breast cancer patients. Eur J Cancer Care. 2013;22(5):673–83.CrossRef
38.
Zurück zum Zitat Vander Meer L, Vallance JK, Ball GDC, Johnson ST. Examining lifestyle information sources, needs, and preferences among breast cancer survivors in Northern British Columbia. Can J Diet Pract Res. 2017;78(4):212–6.CrossRef Vander Meer L, Vallance JK, Ball GDC, Johnson ST. Examining lifestyle information sources, needs, and preferences among breast cancer survivors in Northern British Columbia. Can J Diet Pract Res. 2017;78(4):212–6.CrossRef
39.
Zurück zum Zitat McDonough AL, Lei Y, Kwak AH, Haggett DE, Jimenez RB, Johnston KT, Moy B, Spring LM, Peppercorn J. Implementation of a brief screening tool to identify needs of breast cancer survivors. Clin Breast Cancer. 2021;21(1):e88–95.PubMedCrossRef McDonough AL, Lei Y, Kwak AH, Haggett DE, Jimenez RB, Johnston KT, Moy B, Spring LM, Peppercorn J. Implementation of a brief screening tool to identify needs of breast cancer survivors. Clin Breast Cancer. 2021;21(1):e88–95.PubMedCrossRef
40.
Zurück zum Zitat von Heymann-Horan AB, Dalton SO, Dziekanska A, Christensen J, Andersen I, Mertz BG, Olsen MH, Johansen C, Bidstrup PE. Unmet needs of women with breast cancer during and after primary treatment: a prospective study in Denmark. Acta Oncol (Stockholm, Sweden). 2013;52(2):382–90.CrossRef von Heymann-Horan AB, Dalton SO, Dziekanska A, Christensen J, Andersen I, Mertz BG, Olsen MH, Johansen C, Bidstrup PE. Unmet needs of women with breast cancer during and after primary treatment: a prospective study in Denmark. Acta Oncol (Stockholm, Sweden). 2013;52(2):382–90.CrossRef
41.
Zurück zum Zitat Palmer SC, Blauch AN, Pucci DA, Jacobs LA. Symptom burden, unmet need for assistance, and psychosocial adaptation among longer term breast cancer survivors. Cancer Res. 2017;77:51312. Palmer SC, Blauch AN, Pucci DA, Jacobs LA. Symptom burden, unmet need for assistance, and psychosocial adaptation among longer term breast cancer survivors. Cancer Res. 2017;77:51312.
42.
Zurück zum Zitat Schmid-Buechi S, Halfens RJG, Mueller M, Dassen T, van den Borne B. Factors associated with supportive care needs of patients under treatment for breast cancer. Eur J Oncol Nurs. 2013;17(1):22–9.CrossRef Schmid-Buechi S, Halfens RJG, Mueller M, Dassen T, van den Borne B. Factors associated with supportive care needs of patients under treatment for breast cancer. Eur J Oncol Nurs. 2013;17(1):22–9.CrossRef
43.
Zurück zum Zitat Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res. 2018;27(8):2077–86.PubMedCrossRef Schmidt ME, Wiskemann J, Steindorf K. Quality of life, problems, and needs of disease-free breast cancer survivors 5 years after diagnosis. Qual Life Res. 2018;27(8):2077–86.PubMedCrossRef
44.
Zurück zum Zitat Han S, Won KH, Sung YD, Ran KM. Quality of life and supportive care needs of back-to-work breast cancer survivors. Korean J Adult Nurs. 2019;31(5):552–61.CrossRef Han S, Won KH, Sung YD, Ran KM. Quality of life and supportive care needs of back-to-work breast cancer survivors. Korean J Adult Nurs. 2019;31(5):552–61.CrossRef
45.
Zurück zum Zitat Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G. Breast cancer survivors’ supportive care needs 2–10 years after diagnosis. Support Care Cancer. 2007;15(5):515–23.PubMedCrossRef Hodgkinson K, Butow P, Hunt GE, Pendlebury S, Hobbs KM, Wain G. Breast cancer survivors’ supportive care needs 2–10 years after diagnosis. Support Care Cancer. 2007;15(5):515–23.PubMedCrossRef
46.
Zurück zum Zitat Gilmore KR, Damani S, King RM, Nelson B, Austin A, Scroggs S, et al. A program evaluation of best practice methods to assess integrated health needs for breast cancer survivors. J Clin Oncol. 2014;32(30):111. Gilmore KR, Damani S, King RM, Nelson B, Austin A, Scroggs S, et al. A program evaluation of best practice methods to assess integrated health needs for breast cancer survivors. J Clin Oncol. 2014;32(30):111.
47.
Zurück zum Zitat Tan ASL, Nagler RH, Hornik RC, DeMichele A. Evolving information needs among colon, breast, and prostate cancer survivors: results from a longitudinal mixed-effects analysis. Cancer Epidemiol Biomark Prev. 2015;24(7):1071–8.CrossRef Tan ASL, Nagler RH, Hornik RC, DeMichele A. Evolving information needs among colon, breast, and prostate cancer survivors: results from a longitudinal mixed-effects analysis. Cancer Epidemiol Biomark Prev. 2015;24(7):1071–8.CrossRef
48.
Zurück zum Zitat Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, Admiraal JM, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, et al. Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP. Fam Pract. 2020;37(1):103–9.PubMedCrossRef Lo-Fo-Wong DN, de Haes HC, Aaronson NK, van Abbema DL, Admiraal JM, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MB, et al. Health care use and remaining needs for support among women with breast cancer in the first 15 months after diagnosis: the role of the GP. Fam Pract. 2020;37(1):103–9.PubMedCrossRef
49.
Zurück zum Zitat Thewes B, Butow P, Girgis A, Pendlebury S. Assessment of unmet needs among survivors of breast cancer. J Psychosoc Oncol. 2004;22(1):51–73.CrossRef Thewes B, Butow P, Girgis A, Pendlebury S. Assessment of unmet needs among survivors of breast cancer. J Psychosoc Oncol. 2004;22(1):51–73.CrossRef
50.
Zurück zum Zitat Schmid-Buchi S, Halfens RJG, Dassen T, van den Borne B. Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs. 2011;15(3):260–6.PubMedCrossRef Schmid-Buchi S, Halfens RJG, Dassen T, van den Borne B. Psychosocial problems and needs of posttreatment patients with breast cancer and their relatives. Eur J Oncol Nurs. 2011;15(3):260–6.PubMedCrossRef
51.
Zurück zum Zitat Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Akazawa T, Yamashita H, Toyama T, Furukawa TA. Patient’s perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology. 2011;20(5):497–505.PubMedCrossRef Akechi T, Okuyama T, Endo C, Sagawa R, Uchida M, Nakaguchi T, Akazawa T, Yamashita H, Toyama T, Furukawa TA. Patient’s perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan. Psychooncology. 2011;20(5):497–505.PubMedCrossRef
52.
Zurück zum Zitat Cheng KKF, Devi RD, Wong WH, Koh C. Perceived symptoms and the supportive care needs of breast cancer survivors six months to five years post-treatment period. Eur J Oncol Nurs. 2014;18(1):3–9.PubMedCrossRef Cheng KKF, Devi RD, Wong WH, Koh C. Perceived symptoms and the supportive care needs of breast cancer survivors six months to five years post-treatment period. Eur J Oncol Nurs. 2014;18(1):3–9.PubMedCrossRef
53.
Zurück zum Zitat Chyon MS. Yong Sik Jung MD, Jung Y, 박진희: Changes of supportive care needs and quality of life in patients with breast cancer. Asian Oncol Nurs. 2016;16(4):217–25.CrossRef Chyon MS. Yong Sik Jung MD, Jung Y, 박진희: Changes of supportive care needs and quality of life in patients with breast cancer. Asian Oncol Nurs. 2016;16(4):217–25.CrossRef
54.
Zurück zum Zitat Edib Z, Kumarasamy V, Abdullah NB, Rizal AM, Al-Dubai SAR. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes. 2016;14:26. Edib Z, Kumarasamy V, Abdullah NB, Rizal AM, Al-Dubai SAR. Most prevalent unmet supportive care needs and quality of life of breast cancer patients in a tertiary hospital in Malaysia. Health Qual Life Outcomes. 2016;14:26.
55.
Zurück zum Zitat Fong EJ, Cheah WL. Unmet supportive care needs among breast cancer survivors of community-based support group in Kuching Sarawak. Int J Breast Cancer. 2016;2016:7297813.PubMedPubMedCentralCrossRef Fong EJ, Cheah WL. Unmet supportive care needs among breast cancer survivors of community-based support group in Kuching Sarawak. Int J Breast Cancer. 2016;2016:7297813.PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Lam WWT, Au AHY, Wong JHF, Lehmann C, Koch U, Fielding R, Mehnert A. Unmet supportive care needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer. Breast Cancer Res Treat. 2011;130(2):531–41.PubMedCrossRef Lam WWT, Au AHY, Wong JHF, Lehmann C, Koch U, Fielding R, Mehnert A. Unmet supportive care needs: a cross-cultural comparison between Hong Kong Chinese and German Caucasian women with breast cancer. Breast Cancer Res Treat. 2011;130(2):531–41.PubMedCrossRef
57.
Zurück zum Zitat Mirzaei F, Nourizadeh R, Hemmatzadeh S, Zamiri RE, Farshbaf-Khalili A. Supportive care needs in females with breast cancer under chemotherapy and radiotherapy and its predictors. Int J Womens Health Reprod Sci. 2019;7(3):366–71.CrossRef Mirzaei F, Nourizadeh R, Hemmatzadeh S, Zamiri RE, Farshbaf-Khalili A. Supportive care needs in females with breast cancer under chemotherapy and radiotherapy and its predictors. Int J Womens Health Reprod Sci. 2019;7(3):366–71.CrossRef
58.
Zurück zum Zitat So WK, Chow KM, Chan HY, Choi KC, Wan RW, Mak SS, Chair SY, Chan CW. Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment. Eur J Oncol Nurs. 2014;18(3):323–8.PubMedCrossRef So WK, Chow KM, Chan HY, Choi KC, Wan RW, Mak SS, Chair SY, Chan CW. Quality of life and most prevalent unmet needs of Chinese breast cancer survivors at one year after cancer treatment. Eur J Oncol Nurs. 2014;18(3):323–8.PubMedCrossRef
59.
Zurück zum Zitat Wang S, Li Y, Li C, Qiao Y, He S. Distribution and determinants of unmet need for supportive care among women with breast cancer in China. Med Sci Monit : Int Med J Exp Clin Res. 2018;24:1680–7.CrossRef Wang S, Li Y, Li C, Qiao Y, He S. Distribution and determinants of unmet need for supportive care among women with breast cancer in China. Med Sci Monit : Int Med J Exp Clin Res. 2018;24:1680–7.CrossRef
60.
Zurück zum Zitat Gálvez-Hernández L, Páez-Gerardo I, Ramírez-Medina R, Neri-Flores V, Bargallo-Rocha E, Villarreal-Garza C, et al. Quality of life, unmet needs and social support of patients with breast cancer during adjuvant endocrine therapy in Mexico. Cancer Res. 2019;79(4):12–15. Gálvez-Hernández L, Páez-Gerardo I, Ramírez-Medina R, Neri-Flores V, Bargallo-Rocha E, Villarreal-Garza C, et al. Quality of life, unmet needs and social support of patients with breast cancer during adjuvant endocrine therapy in Mexico. Cancer Res. 2019;79(4):12–15.
61.
Zurück zum Zitat So WKW, Chan CWH, Choi KC, Wan RWM, Mak SSS, Chair SY. Perceived unmet needs and health-related quality of life of chinese cancer survivors at 1 year after treatment. Cancer Nurs. 2013;36(3):E23–32.PubMedCrossRef So WKW, Chan CWH, Choi KC, Wan RWM, Mak SSS, Chair SY. Perceived unmet needs and health-related quality of life of chinese cancer survivors at 1 year after treatment. Cancer Nurs. 2013;36(3):E23–32.PubMedCrossRef
62.
Zurück zum Zitat Chowdhury SH, Banu B, Akter N, Hossain SM. Unmet supportive care needs and predictor of breast cancer patients in Bangladesh: a cross-sectional study. J Oncol Pharm Pract. 2021;28(8):10781552211039114. Chowdhury SH, Banu B, Akter N, Hossain SM. Unmet supportive care needs and predictor of breast cancer patients in Bangladesh: a cross-sectional study. J Oncol Pharm Pract. 2021;28(8):10781552211039114.
63.
Zurück zum Zitat Fong EJ, Cheah WL, Helmy H. Determining unmet needs among breast cancer survivors - an exploratory sequential mixed methods study. Turk Onkoloji Dergisi-Turkish J Oncol. 2019;34(1):1–11. Fong EJ, Cheah WL, Helmy H. Determining unmet needs among breast cancer survivors - an exploratory sequential mixed methods study. Turk Onkoloji Dergisi-Turkish J Oncol. 2019;34(1):1–11.
64.
Zurück zum Zitat Abdollahzadeh F, Moradi N, Pakpour V, Rahmani A, Zamanzadeh V, Mohammadpoorasl A, Howard F. Un-met supportive care needs of Iranian breast cancer patients. Asian Pac J Cancer Prev. 2014;15(9):3933–8.PubMedCrossRef Abdollahzadeh F, Moradi N, Pakpour V, Rahmani A, Zamanzadeh V, Mohammadpoorasl A, Howard F. Un-met supportive care needs of Iranian breast cancer patients. Asian Pac J Cancer Prev. 2014;15(9):3933–8.PubMedCrossRef
65.
Zurück zum Zitat Choi KC, So WKW, Ho SSM, Chan CWH, Mak SSS, Wan RWM, Chair SY. Supportive care needs and quality of life among Chinese breast cancer survivors. Support Care Cancer. 2013;21:S141. Choi KC, So WKW, Ho SSM, Chan CWH, Mak SSS, Wan RWM, Chair SY. Supportive care needs and quality of life among Chinese breast cancer survivors. Support Care Cancer. 2013;21:S141.
67.
Zurück zum Zitat Park BW, Hwang SY. Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J. 2012;53(1):118–25.PubMedCrossRef Park BW, Hwang SY. Unmet needs of breast cancer patients relative to survival duration. Yonsei Med J. 2012;53(1):118–25.PubMedCrossRef
68.
Zurück zum Zitat Park BW, Hwang SY. Unmet needs and their relationship with quality of life among women with recurrent breast cancer. J Breast Cancer. 2012;15(4):454–61.PubMedPubMedCentralCrossRef Park BW, Hwang SY. Unmet needs and their relationship with quality of life among women with recurrent breast cancer. J Breast Cancer. 2012;15(4):454–61.PubMedPubMedCentralCrossRef
69.
Zurück zum Zitat Burris JL, Armeson K, Sterba KR. A closer look at unmet needs at the end of primary treatment for breast cancer: a longitudinal pilot study. Behav Med (Washington, DC). 2015;41(2):69–76.CrossRef Burris JL, Armeson K, Sterba KR. A closer look at unmet needs at the end of primary treatment for breast cancer: a longitudinal pilot study. Behav Med (Washington, DC). 2015;41(2):69–76.CrossRef
70.
Zurück zum Zitat Ellegaard MB, Grau C, Zachariae R, Bonde Jensen A. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncol (Stockholm, Sweden). 2017;56(2):314–320. Ellegaard MB, Grau C, Zachariae R, Bonde Jensen A. Fear of cancer recurrence and unmet needs among breast cancer survivors in the first five years. A cross-sectional study. Acta Oncol (Stockholm, Sweden). 2017;56(2):314–320.
71.
Zurück zum Zitat Chae BJ, Lee J, Lee SK, Shin HJ, Jung SY, Lee JW, Kim Z, Lee MH, Lee J, Youn HJ. Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study. BMC Cancer. 2019;19(1):839.PubMedPubMedCentralCrossRef Chae BJ, Lee J, Lee SK, Shin HJ, Jung SY, Lee JW, Kim Z, Lee MH, Lee J, Youn HJ. Unmet needs and related factors of Korean breast cancer survivors: a multicenter, cross-sectional study. BMC Cancer. 2019;19(1):839.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Vuksanovic D, Sanmugarajah J, Lunn D, Sawhney R, Eu K, Liang R. Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project. Breast cancer (Tokyo, Japan). 2021;28(2):289–97.PubMedCrossRef Vuksanovic D, Sanmugarajah J, Lunn D, Sawhney R, Eu K, Liang R. Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project. Breast cancer (Tokyo, Japan). 2021;28(2):289–97.PubMedCrossRef
73.
Zurück zum Zitat Bu X, Jin C, Fan R, Cheng ASK, Ng PHF, Xia Y, Liu X. Unmet needs of 1210 Chinese breast cancer survivors and associated factors: a multicentre cross-sectional study. BMC Cancer. 2022;22(1):135.PubMedPubMedCentralCrossRef Bu X, Jin C, Fan R, Cheng ASK, Ng PHF, Xia Y, Liu X. Unmet needs of 1210 Chinese breast cancer survivors and associated factors: a multicentre cross-sectional study. BMC Cancer. 2022;22(1):135.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Capelan M, Battisti NML, McLoughlin A, Maidens V, Snuggs N, Slyk P, Peckitt C, Ring A. The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer. Br J Cancer. 2017;117(8):1113–20.PubMedPubMedCentralCrossRef Capelan M, Battisti NML, McLoughlin A, Maidens V, Snuggs N, Slyk P, Peckitt C, Ring A. The prevalence of unmet needs in 625 women living beyond a diagnosis of early breast cancer. Br J Cancer. 2017;117(8):1113–20.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Chou YH, Chia-Rong Hsieh V, Chen X, Huang TY, Shieh SH. Unmet supportive care needs of survival patients with breast cancer in different cancer stages and treatment phases. Taiwan J Obstet Gynecol. 2020;59(2):231–6.PubMedCrossRef Chou YH, Chia-Rong Hsieh V, Chen X, Huang TY, Shieh SH. Unmet supportive care needs of survival patients with breast cancer in different cancer stages and treatment phases. Taiwan J Obstet Gynecol. 2020;59(2):231–6.PubMedCrossRef
76.
Zurück zum Zitat Chua GP, Ng QS, Tan HK, Ong WS. Determining the concerns of breast cancer survivors to inform practice. Asia Pac J Oncol Nurs. 2020;7(4):319–27.PubMedPubMedCentralCrossRef Chua GP, Ng QS, Tan HK, Ong WS. Determining the concerns of breast cancer survivors to inform practice. Asia Pac J Oncol Nurs. 2020;7(4):319–27.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Farrelly A, White V, Meiser B, Jefford M, Young M-A, Ieropoli S, Winship I, Duffy J. Unmet support needs and distress among women with a BRCA1/2 mutation. Fam Cancer. 2013;12(3):509–18.PubMedCrossRef Farrelly A, White V, Meiser B, Jefford M, Young M-A, Ieropoli S, Winship I, Duffy J. Unmet support needs and distress among women with a BRCA1/2 mutation. Fam Cancer. 2013;12(3):509–18.PubMedCrossRef
78.
Zurück zum Zitat Shih IH, Lin CY, Fang SY. Prioritizing care for women with breast cancer based on survival stage: a study examining the association between physical symptoms, psychological distress and unmet needs. Eur J Oncol Nurs. 2020;48: 101816.PubMedCrossRef Shih IH, Lin CY, Fang SY. Prioritizing care for women with breast cancer based on survival stage: a study examining the association between physical symptoms, psychological distress and unmet needs. Eur J Oncol Nurs. 2020;48: 101816.PubMedCrossRef
79.
Zurück zum Zitat Napoles A, Santoyo-Olsson J, Ortiz C, Stewart A. Meeting the post-treatment self-care needs of spanish-speaking latinas after breast cancer. Psychooncology. 2016;25:122. Napoles A, Santoyo-Olsson J, Ortiz C, Stewart A. Meeting the post-treatment self-care needs of spanish-speaking latinas after breast cancer. Psychooncology. 2016;25:122.
80.
Zurück zum Zitat Sleight AG, Lyons KD, Vigen C, Macdonald H, Clark F. Supportive care priorities of low-income Latina breast cancer survivors. Support Care Cancer. 2018;26(11):3851–9.PubMedCrossRef Sleight AG, Lyons KD, Vigen C, Macdonald H, Clark F. Supportive care priorities of low-income Latina breast cancer survivors. Support Care Cancer. 2018;26(11):3851–9.PubMedCrossRef
81.
Zurück zum Zitat Elsous A, Radwan M, Najjar S, Masad A, Abu Rayya M. Unmet needs and health-related quality of life of breast cancer survivors: survey from Gaza Strip, Palestine. Acta Oncol (Stockholm, Sweden). 2023;62(2):194–209.CrossRef Elsous A, Radwan M, Najjar S, Masad A, Abu Rayya M. Unmet needs and health-related quality of life of breast cancer survivors: survey from Gaza Strip, Palestine. Acta Oncol (Stockholm, Sweden). 2023;62(2):194–209.CrossRef
82.
Zurück zum Zitat Burgmann M, Hermelink K, Farr A, Heiduschka A, Van Meegen F, Engel J, et al. Cancer-specific distress, life satisfaction and parenting concerns in young breast cancer survivors. Cancer Res. 2016;76(4):41113. Burgmann M, Hermelink K, Farr A, Heiduschka A, Van Meegen F, Engel J, et al. Cancer-specific distress, life satisfaction and parenting concerns in young breast cancer survivors. Cancer Res. 2016;76(4):41113.
83.
Zurück zum Zitat Gálvez-Hernández CL, Ortega Mondragón A, Villarreal-Garza C, Ramos Del Río B. Young women with breast cancer: Supportive care needs and resilience. Psicooncologia. 2018;15(2):287–300.CrossRef Gálvez-Hernández CL, Ortega Mondragón A, Villarreal-Garza C, Ramos Del Río B. Young women with breast cancer: Supportive care needs and resilience. Psicooncologia. 2018;15(2):287–300.CrossRef
84.
Zurück zum Zitat Beatty L, Oxlad M, Koczwara B, Wade TD. The psychosocial concerns and needs of women recently diagnosed with breast cancer: a qualitative study of patient, nurse and volunteer perspectives. Health Expect. 2008;11(4):331–42.PubMedPubMedCentralCrossRef Beatty L, Oxlad M, Koczwara B, Wade TD. The psychosocial concerns and needs of women recently diagnosed with breast cancer: a qualitative study of patient, nurse and volunteer perspectives. Health Expect. 2008;11(4):331–42.PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Adams N, Gisiger-Camata S, Hardy CM, Thomas TF, Jukkala A, Meneses K. Evaluating survivorship experiences and needs among rural African American breast cancer survivors. J Cancer Educ. 2017;32(2):264–71.PubMedCrossRef Adams N, Gisiger-Camata S, Hardy CM, Thomas TF, Jukkala A, Meneses K. Evaluating survivorship experiences and needs among rural African American breast cancer survivors. J Cancer Educ. 2017;32(2):264–71.PubMedCrossRef
86.
Zurück zum Zitat ArikanDonmez A, Kuru Alici N, Borman P. Lived experiences for supportive care needs of women with breast cancer-related lymphedema: a phenomenological study. Clin Nurs Res. 2021;30(6):799–808.CrossRef ArikanDonmez A, Kuru Alici N, Borman P. Lived experiences for supportive care needs of women with breast cancer-related lymphedema: a phenomenological study. Clin Nurs Res. 2021;30(6):799–808.CrossRef
87.
Zurück zum Zitat Beaver K, Williamson S, Briggs J. Exploring patient experiences of neo-adjuvant chemotherapy for breast cancer. Eur J Oncol Nurs. 2016;20:77–86.PubMedCrossRef Beaver K, Williamson S, Briggs J. Exploring patient experiences of neo-adjuvant chemotherapy for breast cancer. Eur J Oncol Nurs. 2016;20:77–86.PubMedCrossRef
88.
Zurück zum Zitat Chen H-l, Wang X-c, Wang J-b, Zhang J-b. Wang Y: Quality of life in patients with breast cancer and their rehabilitation needs. Pakistan J Med Sci. 2014;30(1):126–30. Chen H-l, Wang X-c, Wang J-b, Zhang J-b. Wang Y: Quality of life in patients with breast cancer and their rehabilitation needs. Pakistan J Med Sci. 2014;30(1):126–30.
89.
Zurück zum Zitat Cheng H, Sit JWH, Cheng KKF. Negative and positive life changes following treatment completion: Chinese breast cancer survivors’ perspectives. Support Care Cancer. 2016;24(2):791–8.PubMedCrossRef Cheng H, Sit JWH, Cheng KKF. Negative and positive life changes following treatment completion: Chinese breast cancer survivors’ perspectives. Support Care Cancer. 2016;24(2):791–8.PubMedCrossRef
90.
Zurück zum Zitat Ddungu H, Kumaketch E, Namisango E. Assessment of clinical and psychological needs of patients with metastatic breast cancer: challenges and gaps in meeting their needs in Uganda. J Glob Oncol. 2018;4:11S.CrossRef Ddungu H, Kumaketch E, Namisango E. Assessment of clinical and psychological needs of patients with metastatic breast cancer: challenges and gaps in meeting their needs in Uganda. J Glob Oncol. 2018;4:11S.CrossRef
91.
Zurück zum Zitat Dsouza SM, Vyasa N, Narayanan P, Parsekar SS, Gore M, Sharan K. A qualitative study on experiences and needs of breast cancer survivors in Karnataka, India. Clin Epidemiol Glob Health. 2018;6(2):69–74.CrossRef Dsouza SM, Vyasa N, Narayanan P, Parsekar SS, Gore M, Sharan K. A qualitative study on experiences and needs of breast cancer survivors in Karnataka, India. Clin Epidemiol Glob Health. 2018;6(2):69–74.CrossRef
92.
Zurück zum Zitat Enzler CJ, Torres S, Jabson J, Ahlum Hanson A, Bowen DJ. Comparing provider and patient views of issues for low-resourced breast cancer patients. Psychooncology. 2019;28(5):1018–24.PubMed Enzler CJ, Torres S, Jabson J, Ahlum Hanson A, Bowen DJ. Comparing provider and patient views of issues for low-resourced breast cancer patients. Psychooncology. 2019;28(5):1018–24.PubMed
93.
Zurück zum Zitat Haynes-Maslow L, Allicock M, Johnson L-S. Cancer support needs for African American breast cancer survivors and caregivers. J Cancer Educ. 2016;31(1):166–71.PubMedCrossRef Haynes-Maslow L, Allicock M, Johnson L-S. Cancer support needs for African American breast cancer survivors and caregivers. J Cancer Educ. 2016;31(1):166–71.PubMedCrossRef
94.
Zurück zum Zitat Hubbeling HG, Rosenberg SM, Cecilia Gonzalez-Robledo M, Cohn JG, Villarreal-Garza C, Partridge AH, et al. Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PloS one 2018;13(5):e0197931. Hubbeling HG, Rosenberg SM, Cecilia Gonzalez-Robledo M, Cohn JG, Villarreal-Garza C, Partridge AH, et al. Psychosocial needs of young breast cancer survivors in Mexico City, Mexico. PloS one 2018;13(5):e0197931.
95.
Zurück zum Zitat Keesing S, Rosenwax L, McNamara B. A call to action: The need for improved service coordination during early survivorship for women with breast cancer and partners. Women Health. 2019;59(4):406–19.PubMedCrossRef Keesing S, Rosenwax L, McNamara B. A call to action: The need for improved service coordination during early survivorship for women with breast cancer and partners. Women Health. 2019;59(4):406–19.PubMedCrossRef
96.
Zurück zum Zitat Landmark BT, Bohler A, Loberg K, Wahl AK. Women with newly diagnosed breast cancer and their perceptions of needs in a health-care context - A focus group study of women attending a breast diagnostic centre in Norway. J Clin Nurs. 2008;17(7B):192–200.PubMedCrossRef Landmark BT, Bohler A, Loberg K, Wahl AK. Women with newly diagnosed breast cancer and their perceptions of needs in a health-care context - A focus group study of women attending a breast diagnostic centre in Norway. J Clin Nurs. 2008;17(7B):192–200.PubMedCrossRef
97.
Zurück zum Zitat Oxlad M, Wade TD, Hallsworth L, Koczwara B. “I’m living with a chronic illness, not … dying with cancer”: a qualitative study of Australian women’s self-identified concerns and needs following primary treatment for breast cancer. Eur J Cancer Care. 2008;17(2):157–66.CrossRef Oxlad M, Wade TD, Hallsworth L, Koczwara B. “I’m living with a chronic illness, not … dying with cancer”: a qualitative study of Australian women’s self-identified concerns and needs following primary treatment for breast cancer. Eur J Cancer Care. 2008;17(2):157–66.CrossRef
98.
Zurück zum Zitat Nápoles AM, Ortiz C, Santoyo-Olsson J, Stewart AL, Lee HE, Duron Y, Dixit N, Luce J, Flores DJ. Post-Treatment Survivorship Care Needs of Spanish-speaking Latinas with Breast Cancer. J Community Support Oncol. 2017;15(1):20–7.PubMedPubMedCentralCrossRef Nápoles AM, Ortiz C, Santoyo-Olsson J, Stewart AL, Lee HE, Duron Y, Dixit N, Luce J, Flores DJ. Post-Treatment Survivorship Care Needs of Spanish-speaking Latinas with Breast Cancer. J Community Support Oncol. 2017;15(1):20–7.PubMedPubMedCentralCrossRef
99.
Zurück zum Zitat Tanjasiri SP, Mata’alii S, Hanneman M, Sabado MD. Needs and experiences of Samoan breast cancer survivors in Southern California. Hawaii Med J. 2011;70(11 Suppl 2):35–9.PubMedPubMedCentral Tanjasiri SP, Mata’alii S, Hanneman M, Sabado MD. Needs and experiences of Samoan breast cancer survivors in Southern California. Hawaii Med J. 2011;70(11 Suppl 2):35–9.PubMedPubMedCentral
100.
Zurück zum Zitat Pembroke M, Bradley J, Nemeth LS. Breast cancer survivors’ unmet needs after completion of radiation therapy treatment. Oncol Nurs Forum. 2020;47(4):436–45.PubMedCrossRef Pembroke M, Bradley J, Nemeth LS. Breast cancer survivors’ unmet needs after completion of radiation therapy treatment. Oncol Nurs Forum. 2020;47(4):436–45.PubMedCrossRef
101.
Zurück zum Zitat Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. Young women with breast cancer: a focus group study of unmet needs. J Adolesc Young Adult Oncol. 2013;2(4):153–60.PubMedPubMedCentralCrossRef Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. Young women with breast cancer: a focus group study of unmet needs. J Adolesc Young Adult Oncol. 2013;2(4):153–60.PubMedPubMedCentralCrossRef
102.
Zurück zum Zitat Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. J Community Support Oncol. 2015;13(9):323–9.PubMedCrossRef Ruddy KJ, Greaney ML, Sprunck-Harrild K, Meyer ME, Emmons KM, Partridge AH. A qualitative exploration of supports and unmet needs of diverse young women with breast cancer. J Community Support Oncol. 2015;13(9):323–9.PubMedCrossRef
103.
Zurück zum Zitat Lo-Fo-Wong DNN, de Haes H, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MBE, Reyners AKL, et al. Risk factors of unmet needs among women with breast cancer in the post-treatment phase. Psychooncology. 2020;29(3):539–49.PubMedCrossRef Lo-Fo-Wong DNN, de Haes H, Aaronson NK, van Abbema DL, den Boer MD, van Hezewijk M, Immink M, Kaptein AA, Menke-Pluijmers MBE, Reyners AKL, et al. Risk factors of unmet needs among women with breast cancer in the post-treatment phase. Psychooncology. 2020;29(3):539–49.PubMedCrossRef
104.
Zurück zum Zitat Palmer SC, DeMichele A, Schapira MM, Glanz K, Blauch A, Pucci DA, et al. Patient-reported outcomes (PROs), unmet need, and psychosocial adaptation among recent breast cancer (BC) survivors. J Clin Oncol. 2016;34(3):212. Palmer SC, DeMichele A, Schapira MM, Glanz K, Blauch A, Pucci DA, et al. Patient-reported outcomes (PROs), unmet need, and psychosocial adaptation among recent breast cancer (BC) survivors. J Clin Oncol. 2016;34(3):212.
105.
Zurück zum Zitat Palmer SC, DeMichele A, Schapira MM, Glanz K, Blauch A, Pucci DA, et al. Association of anxiety and depressive symptoms with differing needs among recent breast cancer (BC) survivors. J Clin Oncol. 2016;34(3):244. Palmer SC, DeMichele A, Schapira MM, Glanz K, Blauch A, Pucci DA, et al. Association of anxiety and depressive symptoms with differing needs among recent breast cancer (BC) survivors. J Clin Oncol. 2016;34(3):244.
106.
Zurück zum Zitat Martinez P, Andreu Y, Conchado A. Psychometric properties of the spanish version of the cancer survivors’ unmet needs (CaSUN-S) measure in breast cancer. Psicothema. 2021;33(1):155–63.PubMed Martinez P, Andreu Y, Conchado A. Psychometric properties of the spanish version of the cancer survivors’ unmet needs (CaSUN-S) measure in breast cancer. Psicothema. 2021;33(1):155–63.PubMed
107.
108.
Zurück zum Zitat Ahmad S, Fergus K, McCarthy M. Psychosocial issues experienced by young women with breast cancer: the minority group with the majority of need. Curr Opin Support Palliat Care. 2015;9(3):271–8.PubMedCrossRef Ahmad S, Fergus K, McCarthy M. Psychosocial issues experienced by young women with breast cancer: the minority group with the majority of need. Curr Opin Support Palliat Care. 2015;9(3):271–8.PubMedCrossRef
109.
Zurück zum Zitat Benedict C, Fisher S, Kuma D, Pollom E, Schapira L, Kurian A, Berek JS, Palesh O. Examining associations among sexual health, unmet care needs related to sexuality, and distress in breast and gynecologic cancer survivors. Ann Behav Med. 2021;55:S605–S605. Benedict C, Fisher S, Kuma D, Pollom E, Schapira L, Kurian A, Berek JS, Palesh O. Examining associations among sexual health, unmet care needs related to sexuality, and distress in breast and gynecologic cancer survivors. Ann Behav Med. 2021;55:S605–S605.
110.
Zurück zum Zitat Miyashita M, Kataoka A, Ohno S, Kawaguchi H, Nishimura J, Murakami S, Ozaki S, Yamaguchi M, Takahashi M. Unmet information needs and quality of life in young breast cancer survivors in Japan. Oncol Nurs Forum. 2011;38(2):E161–2. Miyashita M, Kataoka A, Ohno S, Kawaguchi H, Nishimura J, Murakami S, Ozaki S, Yamaguchi M, Takahashi M. Unmet information needs and quality of life in young breast cancer survivors in Japan. Oncol Nurs Forum. 2011;38(2):E161–2.
111.
Zurück zum Zitat Karis K-FC, Wong WH, Koh C. Symptom burden and unmet needs mediators of quality of life in breast cancer survivors: a structural equation modeling analysis. Psycho-oncology. 2015;24:100–101. Karis K-FC, Wong WH, Koh C. Symptom burden and unmet needs mediators of quality of life in breast cancer survivors: a structural equation modeling analysis. Psycho-oncology. 2015;24:100–101.
112.
Zurück zum Zitat Black KZ, Eng E, Schaal JC, Johnson L-S, Nichols HB, Ellis KR, Rowley DL. The other side of through: young breast cancer survivors’ spectrum of sexual and reproductive health needs. Qual Health Res. 2020;30(13):2019–32.PubMedCrossRef Black KZ, Eng E, Schaal JC, Johnson L-S, Nichols HB, Ellis KR, Rowley DL. The other side of through: young breast cancer survivors’ spectrum of sexual and reproductive health needs. Qual Health Res. 2020;30(13):2019–32.PubMedCrossRef
113.
Zurück zum Zitat Chen M, Li R, Chen Y, Ding G, Song J, Hu X, Jin C. Unmet supportive care needs and associated factors: Evidence from 4195 cancer survivors in Shanghai, China. Front Oncol. 2022;12:1054885.PubMedPubMedCentralCrossRef Chen M, Li R, Chen Y, Ding G, Song J, Hu X, Jin C. Unmet supportive care needs and associated factors: Evidence from 4195 cancer survivors in Shanghai, China. Front Oncol. 2022;12:1054885.PubMedPubMedCentralCrossRef
114.
Zurück zum Zitat Johnston L, Van Der Pols J, Ekberg S. Cancer survivors’ needs, preferences, and experiences accessing dietary information post-treatment: a scoping review. Asia Pac J Clin Oncol. 2020;16(SUPPL 8):171. Johnston L, Van Der Pols J, Ekberg S. Cancer survivors’ needs, preferences, and experiences accessing dietary information post-treatment: a scoping review. Asia Pac J Clin Oncol. 2020;16(SUPPL 8):171.
115.
Zurück zum Zitat Brédart A, Kop JL, Griesser AC, Zaman K, Panes-Ruedin B, Jeanneret W, Delaloye JF, Zimmers S, Jacob A, Berthet V, et al. Validation of the 34-item supportive care needs survey and 8-item breast module French versions (SCNS-SF34-Fr and SCNS-BR8-Fr) in breast cancer patients. Eur J Cancer Care. 2012;21(4):450–9.CrossRef Brédart A, Kop JL, Griesser AC, Zaman K, Panes-Ruedin B, Jeanneret W, Delaloye JF, Zimmers S, Jacob A, Berthet V, et al. Validation of the 34-item supportive care needs survey and 8-item breast module French versions (SCNS-SF34-Fr and SCNS-BR8-Fr) in breast cancer patients. Eur J Cancer Care. 2012;21(4):450–9.CrossRef
116.
Zurück zum Zitat Rammant E, Van Hecke A, Decaestecker K, Albersen M, Joniau S, Everaerts W, Jansen F, Mohamed NE, Colman R, Van Hemelrijck M, et al. Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: a longitudinal study. Psychooncology. 2022;31(2):219–26.PubMedCrossRef Rammant E, Van Hecke A, Decaestecker K, Albersen M, Joniau S, Everaerts W, Jansen F, Mohamed NE, Colman R, Van Hemelrijck M, et al. Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: a longitudinal study. Psychooncology. 2022;31(2):219–26.PubMedCrossRef
117.
Zurück zum Zitat Rimmer B, Crowe L, Todd A, Sharp L. Assessing unmet needs in advanced cancer patients: a systematic review of the development, content, and quality of available instruments. J Cancer Survivor : Res Pract. 2022;16(5):960–75.CrossRef Rimmer B, Crowe L, Todd A, Sharp L. Assessing unmet needs in advanced cancer patients: a systematic review of the development, content, and quality of available instruments. J Cancer Survivor : Res Pract. 2022;16(5):960–75.CrossRef
118.
Zurück zum Zitat Abu-Odah H, Molassiotis A. Yat Wa Liu J: Analysis of the unmet needs of Palestinian advanced cancer patients and their relationship to emotional distress: results from a cross-sectional study. BMC Palliat Care. 2022;21(1):72.PubMedPubMedCentralCrossRef Abu-Odah H, Molassiotis A. Yat Wa Liu J: Analysis of the unmet needs of Palestinian advanced cancer patients and their relationship to emotional distress: results from a cross-sectional study. BMC Palliat Care. 2022;21(1):72.PubMedPubMedCentralCrossRef
119.
Zurück zum Zitat Wang T, Molassiotis A, Chung BPM, Tan JY. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review. BMC Palliat Care. 2018;17(1):96.PubMedPubMedCentralCrossRef Wang T, Molassiotis A, Chung BPM, Tan JY. Unmet care needs of advanced cancer patients and their informal caregivers: a systematic review. BMC Palliat Care. 2018;17(1):96.PubMedPubMedCentralCrossRef
120.
Zurück zum Zitat Miroševič Š, Prins JB, Selič P, Zaletel Kragelj L, Klemenc Ketiš Z. Prevalence and factors associated with unmet needs in post-treatment cancer survivors: a systematic review. Eur J Cancer Care. 2019;28(3): e13060.CrossRef Miroševič Š, Prins JB, Selič P, Zaletel Kragelj L, Klemenc Ketiš Z. Prevalence and factors associated with unmet needs in post-treatment cancer survivors: a systematic review. Eur J Cancer Care. 2019;28(3): e13060.CrossRef
121.
Zurück zum Zitat Ma X, Wan X, Chen C. The correlation between posttraumatic growth and social support in people with breast cancer: a meta-analysis. Front Psychol. 2022;13:1060150.PubMedPubMedCentralCrossRef Ma X, Wan X, Chen C. The correlation between posttraumatic growth and social support in people with breast cancer: a meta-analysis. Front Psychol. 2022;13:1060150.PubMedPubMedCentralCrossRef
122.
Zurück zum Zitat Zhang H, Zhao Q, Cao P, Ren G. Resilience and quality of life: exploring the mediator role of social support in patients with breast cancer. Med Sci Monit : Int Med J Exp Clin Res. 2017;23:5969–79.CrossRef Zhang H, Zhao Q, Cao P, Ren G. Resilience and quality of life: exploring the mediator role of social support in patients with breast cancer. Med Sci Monit : Int Med J Exp Clin Res. 2017;23:5969–79.CrossRef
123.
Zurück zum Zitat Yang Y, Lin Y, Sikapokoo GO, Min SH, Caviness-Ashe N, Zhang J, Ledbetter L, Nolan TS. Social relationships and their associations with affective symptoms of women with breast cancer: a scoping review. PLoS ONE. 2022;17(8): e0272649.PubMedPubMedCentralCrossRef Yang Y, Lin Y, Sikapokoo GO, Min SH, Caviness-Ashe N, Zhang J, Ledbetter L, Nolan TS. Social relationships and their associations with affective symptoms of women with breast cancer: a scoping review. PLoS ONE. 2022;17(8): e0272649.PubMedPubMedCentralCrossRef
124.
Zurück zum Zitat Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48.PubMedCrossRef Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019;177(3):537–48.PubMedCrossRef
125.
Zurück zum Zitat Aubree Shay L, Parsons HM, Vernon SW. Survivorship care planning and unmet information and service needs among adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol. 2017;6(2):327–32.PubMedCrossRef Aubree Shay L, Parsons HM, Vernon SW. Survivorship care planning and unmet information and service needs among adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol. 2017;6(2):327–32.PubMedCrossRef
126.
Zurück zum Zitat Barroso-Sousa R, Jain E, Cohen O, Kim D, Buendia-Buendia J, Winer E, Lin N, Tolaney SM, Wagle N. Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Ann Oncol. 2020;31(3):387–94.PubMedCrossRef Barroso-Sousa R, Jain E, Cohen O, Kim D, Buendia-Buendia J, Winer E, Lin N, Tolaney SM, Wagle N. Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Ann Oncol. 2020;31(3):387–94.PubMedCrossRef
127.
Zurück zum Zitat Perndorfer C, Soriano EC, Siegel SD, Spencer RMC, Otto AK, Laurenceau JP. Fear of cancer recurrence and sleep in couples coping with early-stage breast cancer. Ann Behav Med : Publ Soc Behav Med. 2022;56(11):1131–43.CrossRef Perndorfer C, Soriano EC, Siegel SD, Spencer RMC, Otto AK, Laurenceau JP. Fear of cancer recurrence and sleep in couples coping with early-stage breast cancer. Ann Behav Med : Publ Soc Behav Med. 2022;56(11):1131–43.CrossRef
128.
Zurück zum Zitat Schapira L, Zheng Y, Gelber SI, Poorvu P, Ruddy KJ, Tamimi RM, Peppercorn J, Come SE, Borges VF, Partridge AH, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128(2):335–43.PubMedCrossRef Schapira L, Zheng Y, Gelber SI, Poorvu P, Ruddy KJ, Tamimi RM, Peppercorn J, Come SE, Borges VF, Partridge AH, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128(2):335–43.PubMedCrossRef
129.
Zurück zum Zitat Kuswanto CN, Sharp J, Stafford L, Schofield P. Fear of cancer recurrence as a pathway from fatigue to psychological distress in mothers who are breast cancer survivors. Stress Health. 2022;39(1):197–208. Kuswanto CN, Sharp J, Stafford L, Schofield P. Fear of cancer recurrence as a pathway from fatigue to psychological distress in mothers who are breast cancer survivors. Stress Health. 2022;39(1):197–208.
130.
Zurück zum Zitat Lyu M-M. Siah RC-J, Lam ASL, Cheng KKF: The effect of psychological interventions on fear of cancer recurrence in breast cancer survivors: a systematic review and meta-analysis. J Adv Nurs. 2022;78(10):3069–82.PubMedCrossRef Lyu M-M. Siah RC-J, Lam ASL, Cheng KKF: The effect of psychological interventions on fear of cancer recurrence in breast cancer survivors: a systematic review and meta-analysis. J Adv Nurs. 2022;78(10):3069–82.PubMedCrossRef
131.
Zurück zum Zitat Yang Y, Sun H, Luo X, Li W, Yang F, Xu W, Ding K, Zhou J, Liu W, Garg S, et al. Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients. J Affect Disord. 2022;309:358–67.PubMedCrossRef Yang Y, Sun H, Luo X, Li W, Yang F, Xu W, Ding K, Zhou J, Liu W, Garg S, et al. Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients. J Affect Disord. 2022;309:358–67.PubMedCrossRef
132.
Zurück zum Zitat Singleton AC, Raeside R, Hyun KK, Partridge SR, Di Tanna GL, Hafiz N, Tu Q, Tat-Ko J, Sum SCM, Sherman KA et al. Electronic health interventions for patients with breast cancer: systematic review and meta-analyses. J Clin Oncol. 2022;40(20):2257. Singleton AC, Raeside R, Hyun KK, Partridge SR, Di Tanna GL, Hafiz N, Tu Q, Tat-Ko J, Sum SCM, Sherman KA et al. Electronic health interventions for patients with breast cancer: systematic review and meta-analyses. J Clin Oncol. 2022;40(20):2257.
133.
Zurück zum Zitat Lu H, Xie J, Gerido LH, Cheng Y, Chen Y, Sun L. Information needs of breast cancer patients: theory-generating meta-synthesis. J Med Internet Res. 2020;22(7):e17907. Lu H, Xie J, Gerido LH, Cheng Y, Chen Y, Sun L. Information needs of breast cancer patients: theory-generating meta-synthesis. J Med Internet Res. 2020;22(7):e17907.
134.
Zurück zum Zitat Venetis MK, Staples S, Robinson JD, Kearney T. Provider information provision and breast cancer patient well-being. Health Commun. 2019;34(9):1032–42.PubMedCrossRef Venetis MK, Staples S, Robinson JD, Kearney T. Provider information provision and breast cancer patient well-being. Health Commun. 2019;34(9):1032–42.PubMedCrossRef
135.
Zurück zum Zitat Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: Cancer J Clin. 2016;66(1):43–73. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA: Cancer J Clin. 2016;66(1):43–73.
136.
Zurück zum Zitat Im EO, Kim S, Lee C, Chee E, Mao JJ, Chee W. Decreasing menopausal symptoms of Asian American breast cancer survivors through a technology-based information and coaching/support program. Menopause (New York, NY). 2019;26(4):373–82.CrossRef Im EO, Kim S, Lee C, Chee E, Mao JJ, Chee W. Decreasing menopausal symptoms of Asian American breast cancer survivors through a technology-based information and coaching/support program. Menopause (New York, NY). 2019;26(4):373–82.CrossRef
137.
Zurück zum Zitat Tucholka JL, Yang DY, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Steiman J, Neuman HB. A randomized controlled trial evaluating the impact of web-based information on breast cancer patients’ knowledge of surgical treatment options. J Am Coll Surg. 2018;226(2):126–33.PubMedCrossRef Tucholka JL, Yang DY, Bruce JG, Steffens NM, Schumacher JR, Greenberg CC, Wilke LG, Steiman J, Neuman HB. A randomized controlled trial evaluating the impact of web-based information on breast cancer patients’ knowledge of surgical treatment options. J Am Coll Surg. 2018;226(2):126–33.PubMedCrossRef
138.
Zurück zum Zitat Alinejad Mofrad S, Fernandez R, Lord H, Alananzeh I. The impact of mastectomy on Iranian women sexuality and body image: a systematic review of qualitative studies. Support Care Cancer. 2021;29(10):5571–80.PubMedCrossRef Alinejad Mofrad S, Fernandez R, Lord H, Alananzeh I. The impact of mastectomy on Iranian women sexuality and body image: a systematic review of qualitative studies. Support Care Cancer. 2021;29(10):5571–80.PubMedCrossRef
139.
Zurück zum Zitat Alananzeh I, Green H, Meedya S, Chan A, Chang HC, Yan Z, et al. Sexual activity and cancer: a systematic review of prevalence, predictors and information needs among female Arab cancer survivors. Eur J Cancer Care. 2022;31(6):e13644. Alananzeh I, Green H, Meedya S, Chan A, Chang HC, Yan Z, et al. Sexual activity and cancer: a systematic review of prevalence, predictors and information needs among female Arab cancer survivors. Eur J Cancer Care. 2022;31(6):e13644.
140.
Zurück zum Zitat Luo F, Link M, Grabenhorst C, Lynn B. Low sexual desire in breast cancer survivors and patients: a review. Sex Med Rev. 2022;10(3):367–75.PubMedCrossRef Luo F, Link M, Grabenhorst C, Lynn B. Low sexual desire in breast cancer survivors and patients: a review. Sex Med Rev. 2022;10(3):367–75.PubMedCrossRef
141.
Zurück zum Zitat Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66(1):23–6.PubMedCrossRef Ratner ES, Foran KA, Schwartz PE, Minkin MJ. Sexuality and intimacy after gynecological cancer. Maturitas. 2010;66(1):23–6.PubMedCrossRef
142.
Zurück zum Zitat Tsatsou I, Parpa E, Tsilika E, Katsaragakis S, Batistaki C, Dimitriadou E, Mystakidou K. A systematic review of sexuality and depression of cervical cancer patients. J Sex Marital Ther. 2019;45(8):739–54.PubMedCrossRef Tsatsou I, Parpa E, Tsilika E, Katsaragakis S, Batistaki C, Dimitriadou E, Mystakidou K. A systematic review of sexuality and depression of cervical cancer patients. J Sex Marital Ther. 2019;45(8):739–54.PubMedCrossRef
143.
Zurück zum Zitat Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124(3):477–89.PubMedCrossRef Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124(3):477–89.PubMedCrossRef
144.
Zurück zum Zitat Nimbi FM, Magno S, Agostini L, Di Micco A, Maggiore C, De Cesaris BM, Rossi R, Galizia R, Simonelli C, Tambelli R. Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy. Breast Cancer (Tokyo, Japan). 2022;29(3):419–28.PubMedCrossRef Nimbi FM, Magno S, Agostini L, Di Micco A, Maggiore C, De Cesaris BM, Rossi R, Galizia R, Simonelli C, Tambelli R. Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy. Breast Cancer (Tokyo, Japan). 2022;29(3):419–28.PubMedCrossRef
145.
Zurück zum Zitat Hastert TA, Ruterbusch JJ, McDougall JA, Robinson JRM, Strayhorn SM, Abdallah A, et al. Diagnosis in young adulthood as a risk factor for unmet social needs among African American cancer survivors. Cancer Epidemiol Biomark Prev. 2022;31(1 SUPPL):87. Hastert TA, Ruterbusch JJ, McDougall JA, Robinson JRM, Strayhorn SM, Abdallah A, et al. Diagnosis in young adulthood as a risk factor for unmet social needs among African American cancer survivors. Cancer Epidemiol Biomark Prev. 2022;31(1 SUPPL):87.
146.
Zurück zum Zitat Lou Y, Yates P, Chan RJ, Ni X, Hu W, Zhuo S, Xu H. Unmet supportive care needs and associated factors: a cross-sectional survey of Chinese cancer survivors. J Cancer Educ. 2021;36(6):1219–29.PubMedCrossRef Lou Y, Yates P, Chan RJ, Ni X, Hu W, Zhuo S, Xu H. Unmet supportive care needs and associated factors: a cross-sectional survey of Chinese cancer survivors. J Cancer Educ. 2021;36(6):1219–29.PubMedCrossRef
Metadaten
Titel
Unmet supportive care needs of breast cancer survivors: a systematic scoping review
verfasst von
Rongrong Fan
Lili Wang
Xiaofan Bu
Wenxiu Wang
Jing Zhu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2023
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11087-8

Weitere Artikel der Ausgabe 1/2023

BMC Cancer 1/2023 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.